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FForeword
Injecting is probably the main cause of health damage related to
illegal drug use today. In Europe, drug injecting has been linked
primarily to opiate use — particularly that of heroin —  although,
in some Nordic countries, it is also common among heavy
amphetamine users.
Despite its very low prevalence in general population terms, drug
injecting should nevertheless be considered, in some European
countries, as a public health priority. It is strongly related to fatal
and non-fatal drug overdoses, as well as to the transmission of
infectious diseases, such as hepatitis B, hepatitis C and HIV infec-
tion.
Studying drug injecting is no easy task, largely due to its hidden
nature and low prevalence. Classical epidemiological research
has produced valuable, yet patchy, information on the practice
and on the degree of associated risk. However, there are funda-
mental issues that need to be understood in order to interpret and
better use epidemiological quantitative data on the subject.
From a conventional research perspective, and from the perspective
of the ‘man in the street’, drug injecting is a risky practice and one
which is difficult to comprehend. Despite the potential conse-
quences of this behaviour, some individuals still begin and continue
to inject illegal drugs, generally in very poor conditions.
It is necessary to understand why and how people decide to
engage in such dangerous behaviour. It is therefore important to
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analyse the perceptions and purposes of the injectors themselves,
how they perceive risks and if, or how, they try to avoid them.
On a socio-historical level, drug injecting has been perceived as
a static and long-standing phenomenon. Yet in fact it is a very
dynamic and relatively new one. As a cultural innovation, drug
injecting spread very quickly in western countries in the 1970s
and 1980s and now seems to be spreading rapidly in other
regions of the world, including central and eastern Europe.
Meanwhile, several western countries have reported a recent
trend away from injecting, which may imply that there is room
for improvement and intervention, if only the underlying motiva-
tions of these changes can be understood.    
Qualitative and anthropological research has proved to be a power-
ful tool in understanding drug use. The European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) has been pro-
moting the development of a network of qualitative researchers for
several years and has commissioned a number of projects to create
resources in this area. These include: a European bibliography; a
research database; a specialised web site (http://www.qed.org.uk);
and a scientific monograph (EMCDDA, 2000a).  
Injecting drug use has been a priority topic in EMCDDA projects
on qualitative research and a specific working group was set up
to explore the issue in the late 1990s. The major findings of this
group, released in 1999, provide the foundations of this publica-
tion.
We hope that the wealth of information contained in this edition
of the EMCDDA Insights series will prove to be a valuable
resource for all those carrying out research is this area.
Georges Estievenart
Executive Director
EMCDDA
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IIntroduction
Qualitative research in the field of illicit drug use and addiction
has a long history (Feldman and Aldrich, 1990). This history is
well documented in North America, with the contribution of
qualitative methods in drugs research popularly associated with
the emergence of the Chicago School (Dai, 1937; Singer, 1999).
The post-war period, in particular, produced North-American
ethnographies of drug use which are now considered classics.
These included works which have shaped contemporary social
interactionist drug ethnography, including those by Lindesmith
(1947), Becker (1953), and Finestone (1957), and, more recently,
those by Hughes (1961), Sutter (1966), Preble and Casey (1969),
and Agar (1973). This social-interactionist tradition arguably laid
the foundations not only of drugs research, but also of qualitative
methodology more generally (Becker, 1963; Lindesmith et al.,
1975; Agar, 1980; Knipe, 1995).
Whereas there are historical accounts of North-American qualita-
tive research on drug use (Feldman and Aldrich, 1990; Singer,
1999), the use of qualitative methods in European drugs research
remains largely uncharted. 
In Germany, Spain, France, the Netherlands and the United King-
dom (UK), there is arguably a longer tradition of qualitative
research on drug use than in most European countries. Such
cross-national differences appear to reflect broader country and
cultural differences in research traditions and in the relative status
of social science (especially sociology and anthropology) to psy-
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chiatry, psychology, psychoanalytical approaches, pharmacology,
medicine and epidemiology. Yet there is increasing interest in the
use of qualitative methods as a means of understanding and
responding to illicit drug use (EMCDDA, 2000a).
The advent of HIV infection, and AIDS in particular, brought
about major shifts in the substantive interests of qualitative
researchers, as well as methodological innovations more gener-
ally, including a wave of interest in multi-method research
approaches and research on risk behaviour associated with
injecting drug use (Lambert et al., 1995; Wiebel, 1996).
It is important to note that qualitative research often consists of
multiple methods and data sources. The term ‘qualitative
research’ refers to techniques which seek to generate, collate and
analyse primarily ‘qualitative’ rather than ‘quantitative’ forms of
data.
As shown in Figure 1, qualitative data can be summarised as
information which is based on speech, text or observation and
which is made available to analysis in textual rather than numer-
ical form.
Key techniques of qualitative data collection may therefore
include interviews, focus groups, observations, diaries, written
biographies, oral histories, and other forms of written or visual
documentation. Qualitative studies and, in particular, ethnog-
raphies, therefore tend to adopt multiple-method approaches to
data collection and analysis. Denzin (1970) noted that such stud-
ies involve a ‘blending of methodological techniques’. Ethnog-
raphy has also been described as involving:
‘…some amount of social interaction in the field with the
subjects of the study, some direct observation of relevant
events, some formal and a great deal of informal inter-
viewing, some systematic counting, some collection of
documents and artefacts; and open-endedness in the direc-
tion the study takes.’ (McCall and Simmons, 1969, p. 1;
quoted in Fielding, 1993, p. 157).
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Taken together, the various methods of qualitative research are
oriented towards understanding how people perceive their lives
and construct them as meaningful (Agar, 1980; 1997; Carlson et
al., 1995).
As shall be seen, qualitative research seeks to adopt an ‘inductive
approach’ in an attempt to ‘make sense of, or interpret, phenom-
ena in terms of the meanings people bring to them’ (Denzin and
Lincoln, 1994). It is a ‘method of discovery’ (Fielding, 1993).
Qualitative research works on the basis that the life or behaviour
under study ‘becomes meaningful, reasonable and normal once
you get close to it’ (Goffman, 1961, p. ix). There is probably no
better way to understand people’s experiences, and the meanings
they derive from them, than to speak with them, observe and
spend time with them. In this way, it becomes possible to
describe what they are doing, how they are doing it, and why.
In recognition of a growing interest in the use of qualitative
methods in drugs research, and the varied qualitative research
experience and expertise in Europe in particular, the EMCDDA
commissioned a project to review and synthesise information
published in the last 10 to 15 years on applied qualitative
research on drug use and addiction in the European Union (EU)
(Fountain and Griffiths, 1998).
The recently published EMCDDA scientific monograph Under-
standing and responding to drug use: the role of qualitative
research (EMCDDA, 2000a) indicates that qualitative methods are
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FIGURE 1: AIMS AND TECHNIQUES OF QUALITATIVE RESEARCH
Aim to describe the social meanings actors attach to their actions
to describe actors’ ‘lived experiences’ and lifestyles
to describe the social environments in which action takes
place
Data textual
Data collection observation, interviews, focus groups, diaries, written biog-
raphies, oral histories, photographs
Data analysis inductive, hypothesis generating, systematic case comparison
of critical importance in describing and mapping patterns of drug
use and in developing effective intervention and policy
responses. Part IV of the monograph (Chapters 10 and 11) intro-
duces the subject of risk behaviour in anticipation of this fourth
edition of the EMCDDA Insights series. This present publication
focuses in depth on the role of qualitative research in under-
standing injecting drug use and its adverse health consequences,
particularly risk behaviour associated with HIV transmission.
Emerging out of a review paper produced by the EMCDDA work-
ing group on injecting drug use and risk behaviour, this volume
does not aim to provide an exhaustive review of the literature.
Neither does it aim to offer a methodological guide. Rather, it
seeks to synthesise examples drawn from selected studies in an
attempt to clarify the role of qualitative research in understanding
health-related risk behaviours associated with injecting drug use.
As the name of this EMCDDA series suggests, the object is to
highlight the ‘insights’ to be gained by using qualitative methods
in drugs research.
The first section of the book briefly summarises the health-related
harms most commonly associated with drug injecting and pro-
vides a backdrop for the rest of the publication. As described in
subsequent sections, qualitative understandings of risk behaviour
are important, not only for identifying and describing how spe-
cific injecting practices relate to the risk of ill-health, but also for
capturing the meanings that different individuals and groups
attach to drug injecting and risk behaviours, and, crucially, for
developing appropriate risk-reduction interventions.
While it is the case that quantitative survey methods and positivist
paradigms remain dominant in the drugs and health research
fields, there is increased recognition that qualitative methods
have the capacity to inform survey designs and complement
quantitative findings. Importantly, and in their own right, qualita-
tive data provide the means for interpreting behaviours which
might otherwise seem inexplicable. This is particularly the case
among ‘hidden’ or ‘hard-to-reach’ populations — such as inject-
ing drug users — where practical and methodological difficulties
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exist in using large-scale survey methods based on statistically
representative sampling designs.
Qualitative methods may be considered an essential component
of multiple-method approaches to drugs research and particularly
useful for providing the data necessary for developing risk-
reduction interventions. Particular attention may be drawn to its
role in:
• reaching and researching hidden populations;
• understanding the ‘lived experiences’ and meanings of drug
use;
• understanding the social contexts of drug use;
• informing quantitative research;
• complementing and questioning quantitative research; and
• informing the development of effective intervention and policy
responses.
In the following pages we hope to highlight the benefits afforded
by the use of qualitative methods in drugs research, particularly
research related to injecting drug use and risk behaviour.
Tim Rhodes, PhD
Senior Lecturer in Sociology of Health
Centre for Research on Drugs and Health Behaviour
Department of Social Science and Medicine
Imperial College School of Medicine, University of London
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INTRODUCTION
Injecting drug use is associated with a variety of functions, pleas-
ures and harms. The bulk of research in this area has focused on
harmful consequences associated with crime, income generation,
health, social welfare, education and employment, and has
revealed that such costs have individual, as well as wider com-
munity, implications.
Our focus here lies with the health-related harms and risk behav-
iours associated with drug injecting. Precisely what constitutes a
health-related harm is subject to differences in experience, opinion
and context. At the outset, it should be stated that there is no single
definition or shared rationality for what constitutes a risk or harm
(Rhodes, 1995). Not only is it likely that different understandings of
risk behaviour or harm will exist between different injecting drug
users (IDUs), but also that such differences are likely to depend on
transitions in patterns of drug use as well as the social, economic
and political contexts in which drug injecting occurs.
HIV INFECTION AND AIDS
While accepting that understandings of risk and harm are multi-
ple, it is clear that drug injecting carries with it the potential for
major public health problems. One of the most evident is HIV
infection.
In a number of global regions, including some eastern and south-
western European countries (Ball et al., 1998; Crofts et al., 1998;
Rhodes et al., 1999a; 1999b), injecting drug use — or, more
specifically, the shared use of injecting equipment — has consti-
tuted the predominant means of HIV transmission.
As of the end of 1998, at least one third of national reported AIDS
cases were associated with drug injecting in Spain, Ireland, Italy
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and Portugal, with at least one quarter associated with drug
injecting in France and Austria (EMCDDA, 1999a). In parts of
eastern Europe — including the newly independent States of
Belarus, Moldova, Russia and the Ukraine — HIV associated with
drug injecting accounts for at least 50 % of registered HIV cases,
and as many as 90 % in some areas (Rhodes et al., 1999b).
Table 1, which is based on data provided by the Paris-based 
Centre européen pour la surveillance epidémiologique du SIDA
(European centre for the epidemiological monitoring of AIDS),
shows the incidence of drug-related AIDS cases in each EU 
Member State from 1985–99 (EMCDDA, 2000b).
Injecting drug use is currently reported by 129 countries and ter-
ritories, of which 103 also report associated HIV (Ball et al.,
1998). HIV transmission associated with drug injecting can
spread extremely rapidly, with HIV prevalence among IDUs rising
from virtually zero to 40 % within one to two years in some cases
(Ball et al., 1998; Strathdee et al., 1998; Rhodes et al., 1999a).
As shown in Table 2, the recent spread of HIV associated with
drug injecting has been explosive in parts of eastern Europe, as
indicated by the exponential rise in the number of registered HIV-
positive IDUs since 1994 (known to be an underestimate).
Once HIV prevalence is high, it may take some time before it sta-
bilises or declines (Davies et al., 1995; Des Jarlais et al., 1998),
but even a decline may mask ongoing transmission among young
IDUs and recent initiates to drug injecting. HIV associated with
drug injecting continues to present major public health costs —
human, financial and social — in European countries, such as
Spain, France, Italy and the Netherlands, and parts of eastern
Europe (Dehne et al., 1999; EMCDDA, 1999a; Rhodes et al.,
1999b). Figure 2 summarises HIV prevalence data among IDUs in
the EU (EMCDDA, 1999a).
Understanding the dynamics of HIV-related risk behaviour pro-
vides a key means to mapping and preventing HIV epidemics.
HIV transmission is known to be associated with the sharing of
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used injecting equipment, but ‘sharing’ practices vary widely
depending on an interplay of social, contextual, economic and
political factors.
Syringe sharing, for example, is not merely a product of individu-
als’ risk calculus (Latkin et al., 1994), but is also contextually
determined by: peer groups and cultural ‘norms’ (Zule, 1992;
Friedman et al., 1997); paraphernalia laws, drug policing and law
enforcement (Grund et al., 1992a; Koester, 1994; Lurie and
Drucker, 1997); injecting equipment availability (Hurley, Jolley
and Kaldor, 1997); gender, ethnic and health inequalities
(Barnard, 1993a; Friedman et al., 1998); the political and social
economy (Grund et al., 1992a; Singer, 1998); and, perhaps most
importantly, public health policy (Drucker et al., 1998; Strathdee
et al., 1998).
Qualitative understandings of the social context of risk behaviour
are paramount in understanding HIV infection, and HIV-related
risk behaviour, as products of the particular ‘risk environments’ in
which they occur.
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FIGURE 2: HIV PREVALENCE AMONG IDUS IN THE EU
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HEPATITIS
In many European countries, public health concerns associated
with the transmission of hepatitis have been eclipsed by concerns
about HIV. However, while the prevalence of hepatitis B virus
(HBV) infection among IDUs has fallen in many European coun-
tries over the past decade (EMCDDA, 1999a), data from Spain,
the Netherlands, Austria and Sweden indicate that over half of
IDUs are HBV antibody positive (Wiessing et al., 1998a; 1998b).
Approximately 40 % of IDUs have been found to be HBV posi-
tive in studies in Germany and Italy (EMCDDA, 1999a). Whereas
community-recruited surveys found over 50 % of London IDUs to
be HBV positive in the early to mid-1990s (Rhodes et al., 1996),
the latest estimates, also drawn from community-recruited 
surveys, indicate HBV prevalence of under 20 % (Hickman et al.,
1999; Judd et al., 1999a).
Since the introduction of measures to prevent hepatitis C virus
(HCV) transmission through blood products, injecting drug use
has accounted for the majority of new HCV infections, with
prevalence among IDUs ranging between 50 and 90 %, and inci-
dence rates between 10 and 20 % per year (Judd et al., 1999b).
Most recent estimates in Europe suggest that over 50 % of IDUs are
HCV positive (van Ameijden et al., 1993; Galeazzi et al., 1995;
Serfaty et al., 1997; Broers et al., 1998; Lamden et al., 1998), with
estimates of over 80 % in parts of Greece, Spain, Ireland, the
Netherlands, Portugal and Sweden (Wiessing et al., 1998a; 1998b;
EMCDDA, 1999a). It is estimated that approximately 500 000 IDUs
are HCV positive in the EU (Nalpas et al., 1996). Most studies show
HCV prevalence rising steadily with length of injecting career and
increasing age (Crofts et al., 1997; Broers et al., 1998; van Beek et
al., 1998), though frequency of injecting, injection equipment shar-
ing, and co-infection with HIV or HBV have also been identified as
risk factors (van Beek et al., 1994; Galeazzi et al., 1995; Lamden et
al., 1998). Figure 3 summarises reported HBV and HCV antibody
prevalence among IDUs in the EU (EMCDDA, 1999a).
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In general, there is little evidence of declines in HCV prevalence
among IDUs. One exception appears to be the UK. Among IDUs
seeking named HIV antibody tests, HCV prevalence fell from
90 % in 1990 to 77 % in 1995 (Goldberg et al., 1998). A recent
prevalence study among 740 community-recruited IDUs in Eng-
land found lower than expected HCV prevalence (under 40 %),
with 15 % HCV positivity among those with injecting careers of
under six years and 10 % among those with injecting careers of
under two years (Hickman et al., 1999).
These studies hypothesise that HCV positivity remains low among
those who began injecting after harm-reduction interventions had
been established, and this suggests that harm reduction may have
had positive HCV prevention impact (Goldberg et al., 1998;
Hickman et al., 1999). It is important to note, however, that it is
only comparatively recently that epidemiological studies have
begun to estimate the determinants and distribution of HCV
among IDUs, and there remains a need for qualitative studies to
inform the development of more sensitive measures of HCV-
related risk behaviour. There are few published ethnographic
22
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FIGURE 3: ANTIBODIES TO HEPATITIS B AND C AMONG IDUS IN THE EU
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studies on the ‘lived experience’ of HCV risk behaviour, positive
diagnosis and associated risk management.
OVERDOSE
In western Europe, opioid users have a risk of premature death
that is 20–30 times higher than their peers who do not use drugs
(Joe and Simpson, 1987; Davoli et al., 1993; 1997; Frischer et al.,
1997; EMCDDA, 1999a; Hulse et al., 1999).
In Rome, for example, male IDUs have a risk of death that is 15
times higher, and female IDUs 30 times higher, than would be
expected in the general population (Davoli et al., 1997). One 22-
year follow-up study among UK opioid users found an annual mor-
tality rate of 1.8 %, 12 times greater than the general population
(Oppenheimer et al., 1994). In Glasgow, Scotland, IDUs were
found to be 22 times more likely to die than their peers (Frischer et
al., 1997), with follow-up studies showing a 1.8 % mortality rate.
Since the mid-1980s, sharp increases in mortality rates among
IDUs have been associated with the emergence of HIV/AIDS in
some countries, including Spain, France and Italy (Davoli et al.,
1993; 1997; Orti et al., 1996; Mezzelani et al., 1998). However,
European studies also show high mortality rates among HIV-
negative IDUs (EMCDDA, 1999b).
In the UK, 60 % of addicts’ deaths are related to drug use, mainly
from overdose (Ghodse et al., 1998), and drug-related deaths
have been on the increase since 1984. In Glasgow, where almost
one third of all deaths among people aged between 15 and 33
years are drug-related, 90 % of addict deaths are related to over-
dose or suicide, with 2 % caused by HIV-related disease (Frischer
et al., 1997).
While there is considerable European variability in definitions
and methods of recording drug deaths (including ‘overdose’), as
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well as in recent mortality trends, (overdose — which is prevent-
able — remains a major cost related to drug use and addiction
(WHO, 1999). Table 3 shows that, until recently, drug-related
deaths were on the increase in most EU Member States and still
are in some cases (EMCDDA, 2000b).
Research also shows non-fatal overdose to be common. An Aus-
tralian sample of 329 IDUs yielded a 68 % prevalence of non-fatal
heroin overdose (Darke et al., 1996a; 1996b). Approximately one
third had overdosed in the previous 12 months. A study among
1 018 IDUs in Glasgow found that 27 % had reported at least one
non-fatal overdose which required medical attention in the previ-
ous 12 months (Taylor et al., 1996). A national survey among 2 051
drug users in Norway, two thirds of which had reported opioid use
in the previous six months, found 45 % to have experienced one or
more life-threatening overdoses. Unpublished data from Brussels
show that 33 % of IDUs reported having had at least one overdose,
with a mean of 3.5 overdoses reported (Hariga, 1999). The preva-
lence of non-fatal overdose indicates the high risk of overdose-
related morbidity.
Epidemiological research has identified a number of risk factors
for non-fatal opioid overdose (Darke et al., 1996a; Taylor et al.,
1996; Davoli et al., 1997; Seaman et al., 1998). These include:
• injection, rather than smoking or snorting, of heroin;
• variations in drug purity and supply;
• miscalculations made by drug users when testing the strength of
drugs prior to use;
• concurrent use of other substances in addition to opioids
(particularly alcohol, benzodiazepines and barbiturates); and
• recent release from prison.
Studies also identify overdose itself as a risk factor, with the
chance of a further overdose increasing for each overdose
reported (Powis et al., forthcoming). With the majority of non-
fatal overdoses occurring in the company of others (Darke et al.,
1996b; Powis et al., forthcoming), and as overdose is prevent-
able, qualitative studies have a key role to play in understanding
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the dynamics of overdose situations and in informing the devel-
opment of prevention and risk management interventions.
An understanding of IDUs’ perceptions of risk associated with
overdose, their attitudes and responses to overdose and their
overdose prevention, risk management and coping strategies is
pivotal to developing effective responses to prevent overdose and
overdose fatalities.
SEXUAL HEALTH RISKS
While it is recognised that drug use intersects with sexual behav-
iour in multiple ways, the sexual health of drug-using populations
has often been neglected by researchers and interventionists.
In public health terms, sexual risk among IDUs is largely equated
with condom use and the need to prevent sexually transmitted infec-
tions (STIs) associated with unprotected sex. 
Studies indicate that the sexual transmission of HIV among IDUs
remains a significant concern, particularly in areas in which HIV or
other STI epidemics are established, and where drug use intersects
with sex work (van den Hoek et al., 1992; Battjes et al., 1994;
Rhodes et al., 1998; 1999b). 
Qualitative studies of sexual negotiation and risk behaviour among
IDUs and their sexual partners are clearly important for developing
sexual risk-reduction interventions. Better understanding of the role
of social context in mediating drug use and its perceived effects on
sexual behaviour, and of the perceived impact of drug use on the
quality of sexual relationships, is helpful in recognising the variety of
ways in which drug injecting intersects with sexual health.
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OTHER INFECTIONS
In addition to HIV and hepatitis, drug injecting may also be asso-
ciated with the transmission of other blood-borne, bacterial, fun-
gal and parasitic infections (Donoghoe and Wodak, 1998). The
majority of hospital admissions of IDUs, as well as admissions to
emergency care, may be associated with endocarditis, abscesses,
thrombophlebitis and other local complications associated with
injecting (Scheidegger and Zimmerli, 1989; Makower et al.,
1992).
Mortality from infective endocarditis among IDUs has been esti-
mated to range between 15 % and 92 %, and is a common cause
of death among HIV-positive IDUs (English et al., 1995).
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INTRODUCTION
HIV infection and AIDS have had a major impact on the substantive
interests as well as methodological parameters of drug use research,
and have arguably been a catalyst to greater methodological flexi-
bility, experimentation and innovation (Boulton, 1994; Lambert et
al., 1995; Singer, 1999). In fact, the time of AIDS may come to sym-
bolise a key historical moment in the contemporary development of
qualitative methods in drugs research (Herdt and Lindenbaum,
1992; Singer, 1999; Rhodes, 2000a; forthcoming).
This chapter aims to summarise key historical developments in
the use of qualitative methods in North-American drugs research
up until the time of AIDS (here loosely defined as the mid-1980s).
Developments in North-American drugs ethnography arguably
laid the foundations for contemporary qualitative research on
drug use. Also outlined is the growth of European interest in con-
ducting qualitative research on drug use and HIV-related risk
behaviour in the last 10 to 15 years.
THE TIME BEFORE AIDS
It is said that the beginnings of modern qualitative research on
drug use can be traced to De Quincey’s Confessions of an English
opium eater (1822), where the method employed was akin to par-
ticipant observation (Feldman and Aldrich, 1990). Over a number
of years, De Quincey described the use of opium (which, prior to
the invention of the hypodermic needle in 1865, was imbibed in
liquid form) among the urban poor in London, as well as his own
experiments with the drug.
Singer (1999) suggests that another notable ‘ethnographic’
account of drug use which emerged during the same period was
that of Engels, who, in The conditions of the working class in
1844, noted how the use of opium (primarily laudanum) and
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alcohol among the urban poor of Manchester in the UK func-
tioned as a means of escape (Engels, 1969).
The methodological origins of applied qualitative research may
be traced to social interactionism in sociology, which emerged in
the 1920s and 1930s, led by the Chicago School (Znaniecki,
1934; Carey, 1975). These developments emphasised the socially
situated nature of individual action, and demonstrated the value
of integrating multiple methods to understand the subjective
meanings and social contexts of behaviour, giving rise to a num-
ber of ethnographies in drug use, criminality and deviance
(Anderson, 1923; Shaw, 1930; Dai, 1937; Whyte, 1955).
This is the genesis of qualitative research as a means of under-
standing drug use as socially constructed, and of encouraging
intervention developments coherent with local practices in differ-
ent cultural settings. Chicago School ethnography thus sought to
describe in detail a particular ‘community, group or situation’
(Hammersley, 1992), and the first such drug ethnography is often
attributed to Dai and his Opium addiction in Chicago, where he
attempted to understand drug users ‘as a group’ in the context of
‘the world they live in’ (1937, p. 645).
Building on the principles of social interactionism, post-war qual-
itative studies on drug use have been of note not only for the
social explanations of drug use and addiction they provided, but
also for their insights into qualitative methodology, and theorising
on social deviance more generally (Lindesmith, 1947; Becker,
1953; 1963; Agar, 1973; Lindesmith et al., 1975; Weppner,
1977).
The clandestine nature of many drug-use behaviours and ‘sub-
cultures’ has provided ideal terrain for the development of what are
now considered classic ethnographies of drug use and hidden pop-
ulations (Becker, 1953; Sutter, 1966; Preble and Casey, 1969; Agar,
1973; Jackson, 1978). In the tradition of ethnography, the focus of
such research was to ‘make sense’ of the social world of drug use
from the perspectives of drug users. Drawing on a variety of tech-
niques, including direct observations and face-to-face interviews,
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these studies sought to describe the everyday context of behaviours
and lifestyles otherwise misunderstood or hidden from view.
Drug ethnographies between the late 1950s and 1970s countered
popular perceptions of drug users as passive or deviant with alter-
native images of drug use and drug users’ lifestyles as purposeful
and active (Finestone, 1957; Hughes, 1961; Becker, 1963; Preble
and Casey, 1969; Agar, 1973; Feldman et al., 1979). Additionally,
they understood drug use and addiction as being inextricably
bound with the situational and lifestyle contexts in which drug
use occurred, including in relation to urban city life, political and
economic economy, migration and recreational or leisure activity
(Finestone, 1957; Lindesmith et al., 1975; Singer, 1999).
As was noted at the time: ‘addicts become addicted not only to
drugs but to a way of life’ (Lindesmith et al., 1975, p. 571). As
ethnographies of LSD (Becker, 1970), PCP (Feldman et al., 1979),
urban heroin use (Finestone, 1957; Hughes, 1961; Sutter, 1966;
Preble and Casey, 1969; Agar, 1973), methadone (Preble and
Miller, 1977), drugs in prison, and alcohol (Spradley, 1970)
demonstrated, popularly misunderstood behaviours were discov-
ered to be rational and normal when understood from the per-
spectives of drug users and when ‘situated’ within the social con-
texts in which they occurred.
Key North-American qualitative studies in this area are arguably
those of Finestone (1957), Sutter (1966), Preble and Casey (1969)
and Agar (1973). Based on 50 qualitative interviews with African-
American heroin users, Finestone’s (1957) was one of the first
studies to establish a grounded world-view of heroin use as nor-
mal and rational (Singer, 1999). Centring on ‘the cat’ (an apt
image depicting the African-American heroin user), ‘the hustle’
(illegal activities to generate revenue) and ‘the kick’ (the use of
drugs), Finestone’s study marked a shift from ‘asking why people
used drugs’ towards exploring ‘how they went about getting
involved in drug use’ (Feldman and Aldrich, 1990, p. 19).
Sutter’s study — ‘The world of the righteous dope fiend’ (1966) —
noted the processes, positive qualities and functions of maintain-
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ing status in drug-user hierarchies, findings which were later par-
alleled by the ethnographic work of Feldman (1973). Similarly,
Preble and Casey’s seminal paper, ‘Taking care of business’,
described heroin use as ‘anything but an escape from life’, in
which drug users were ‘actively engaged in meaningful activities
and relationships seven days a week’ wherein the ‘quest for
heroin is the quest for a meaningful life’ (1969, p. 2).
Likewise, Agar’s Ripping and running (1973), as well as Waldorf’s
Careers in dope (1973), ran counter to the ‘received view’ of
IDUs’ lifestyles by illustrating how this particular way of life was
active and purposeful and made sense from the perspectives of
IDUs themselves. Qualitative research between the 1950s and
1970s had, to some extent, facilitated a shift away from depic-
tions of addiction derived from medicine, psychology and psy-
chiatry to those grounded in drug users’ own experiences and
perspectives (Feldman and Aldrich, 1990; Singer, 1999). Figure 4
offers an overview of the developments in qualitative research on
drug use since the early 1800s.
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FIGURE 4: DEVELOPMENTS IN QUALITATIVE RESEARCH ON DRUG USE
1800s Informal observations and participant observations
Examples: De Quincey (1822), Engels (1844)
1920s–1940s Social-interactionist studies of the Chicago School
Examples: Shaw (1930), Dai (1937), Lindesmith (1947)
1950s–1960s Social-interactionist studies in drug ethnography
Examples: Becker (1953), Finestone (1957), Sutter (1966)
1970s–1980s Social-interactionist studies of urban/drug ‘lifestyle’
and ‘career’
Examples: Agar (1973), Feldman (1973), Waldorf (1973)
1980s–1990s Multi-method studies of drug use, risk (AIDS) and context
Examples: Pearson (1987), Grund (1993), Gamella (1994)
In the time before AIDS, most qualitative research on drug use,
including injecting drug use, was therefore characterised by
attempts to provide rich descriptions of hidden populations of
drug users and their ‘socially deviant’ lifestyles. The substantive
interests were less likely to be driven by public health concerns
about the potential risks associated with injecting than by explo-
rations of why people used drugs — a key focus of drugs research
in the pre-war period — and how people used drugs — a key
focus of drugs research in the post-war period, as well as the time
immediately before AIDS (Singer, 1999).
The key thrust of qualitative research in the time immediately
before AIDS was, therefore, the exploration of drug use as an
inextricable feature of social circumstances and ‘sub-cultures’
which made little rational or moral sense to ‘outsiders’. As noted
by Singer (1999), North-American drug ethnographies of the late
1970s and mid-1980s largely proffered accounts from a ‘drug-
user perspective’ and invited a holistic image of the drug ‘sub-
culture’, ‘career’, and ‘lifestyle’ (Feldman et al., 1979; Rosenbaum,
1981; Hanson et al., 1985; Johnson et al., 1985). As has been
noted of the role of ethnography more generally, the aim is to
undertake a ‘study of culture from within’ (James, 1977, p. 180).
THE TIME OF AIDS
The arrival of HIV infection and AIDS brought about considerable
changes in the use of qualitative methods in drugs research. This
shift can be traced to the mid-1980s with the discovery that HIV
infection was spreading ‘epidemically’ among populations of
IDUs through the shared use of injecting equipment and through
unprotected sex.
In Europe, this was found to be particularly the case in (western)
Germany (Heckmann et al., 1993; Pant and Kleiber, 1993), Spain
(Anchuela et al., 1994; de la Fuente et al., 1994), France (Ingold
and Toussirt, 1997), Italy (Rezza et al., 1994; Davoli et al., 1995)
and Edinburgh in the UK (Robertson et al., 1986).
At the time that HIV was becoming evident among IDUs, a number
of European ethnographies were investigating the social and eco-
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nomic context of new waves of heroin use and injection, said to
have peaked in the early to mid-1980s. Principal among these were:
• Pearson’s The new heroin users (1987) in Manchester in the
north-west of England;
• Taylor’s Women drug users (1993) in Glasgow (the first ethnog-
raphy of a female injecting community);
• Gamella’s life history studies of the diffusion of heroin and drug
injecting in Spain (1993; 1994; 1997a; 1997b);
• Pallares’ ethnography El placer del escorpión (1996) of heroin
use between 1970 and 1990 in Barcelona;
• Noller and Reinicke’s Heroinszene (1987) and Noller’s follow-
up Junkie-maschinen (1989) in Frankfurt;
• van Gelder and Sijtsma’s Horse, coke en kansen (1988) in Ams-
terdam; and
• Grund’s Drug use as a social ritual (1993) in Rotterdam.
These, and other European ethnographic studies since the mid-
1980s (Hakkarainen, 1989; Romaní, 1992; Ruggiero, 1992;
Zurhold, 1993; Fernandes, 1995; Svensson, 1996), drew on the
concepts of drug ‘career’ and ‘lifestyle’ emerging from North-
American ethnographies. They aimed to describe how social and
economic shifts associated with unemployment and housing
influenced patterns of drug use and injecting, and provided a
descriptive backdrop for understanding the wider ‘risk environ-
ment’ associated with drug use.
Coinciding with increased concerns associated with HIV trans-
mission, these studies also attempted, to a varying extent, to cap-
ture descriptive data on risk behaviour. Gamella’s study among
the ‘yonquis’ (junkies) of a neighbourhood in northern Madrid, for
example, observed high levels of needle and syringe sharing in
the early to mid-1980s resulting in unexpectedly high levels of
HIV prevalence (of over 50 %) within IDU networks (Gamella,
1991; 1993; 1994; 1997c). Similarly, Grund’s studies on the ritu-
als of social regulation associated with patterns of heroin smoking
and injecting led him to observe, describe and define a range of
injecting behaviours associated with HIV transmission (Grund et
al., 1990; 1991; 1993; 1996).
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From the mid-1980s onwards, the health risks associated with
drug injecting became a key feature of drugs research — particu-
larly in Spain, France, Italy, the Netherlands and the UK —  with
HIV constituting a major public health issue demanding policy-
relevant research. This concern prompted a flurry of activity char-
acterised by an unusual alliance between epidemiology and
ethnography as researchers within each of these disciplines grap-
pled to understand the dynamics of the spread of HIV (Boulton,
1994; Wiebel, 1996).
At the time, an important epidemiological objective was to
ascertain the prevalence and incidence of HIV and AIDS among
IDUs, both to assess the current situation and to model its future
spread. This led to a number of primarily quantitative studies of
HIV prevalence and related risk behaviour in the EU, including
the following:
• Belgium (Peeters, 1990; Todts et al., 1990; 1997);
• Denmark (Ege, 1989; Hedburg and Gaub, 1995; Sorensen et
al., 1995);
• Germany (Hamouda et al., 1993; Heckmann et al., 1993; Pant
and Kleiber, 1993);
• Greece (Papaevangelou et al., 1991; Kokkevi et al., 1992);
• Spain (Zunzunegui-Pastor, 1993; Anchuela et al., 1994; de la
Fuente et al., 1994);
• France (Ingold and Toussirt, 1997; Rotilly, 1997);
• Ireland (Johnson et al., 1994; O’Gorman, 1998);
• Italy (Nicolosi et al., 1992; Rezza et al., 1994; Davoli et al.,
1995);
• the Netherlands (van Ameijden et al., 1993);
• Portugal (Costa, 1994; 1997; Godinho et al., 1996);
• Finland (Leinikki et al., 1996; Poikolainen, 1997; Vuori et al.,
1997);
• Sweden (Ljungberg et al., 1991; Krook et al., 1997); and
• the United Kingdom — in London (Rhodes et al., 1993; 1996;
Stimson et al., 1996), in Glasgow (Frischer et al., 1992; Taylor
et al., 1994) and in Edinburgh (Robertson et al., 1986; Davies et
al., 1995).
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To a large extent, these epidemiological studies provided the back-
drop for qualitative investigations on risk behaviour among IDUs.
Taken together, they indicated varying HIV prevalence among IDUs
within and across different European cities over time, with reports of:
• ‘low’ (i.e. under 5 %) and ‘stabilised’ prevalence in Belgium
(Todts et al., 1997), former East Germany (Hamouda et al.,
1993), Greece (Papaevangelou et al., 1991), Lund and
Stockholm, Sweden (Ljungberg et al., 1991; Krook et al., 1997),
Glasgow, Scotland (Taylor et al., 1994), and in London since
1994 (Stimson et al., 1996);
• fluctuations in ‘low’ to ‘medium’ prevalence over time (i.e.
5–20 %) in the cities of Amsterdam (van Ameijden et al., 1993),
Berlin (Stark and Kleiber, 1991; Pant and Kleiber, 1993),
Hamburg (Heckmann et al., 1993), Dublin (Johnson et al.,
1994), Paris (Ingold and Toussirt, 1997) and London prior to
1994 (Rhodes et al., 1993; Stimson et al., 1996);
• ‘medium’ prevalence (20–40 %) in the cities of Rome (Abeni et
al., 1998) and Edinburgh (Davies et al., 1995); and
• ‘high’ prevalence (over 40 %) in Milan (Nicolosi et al., 1992;
Rezza et al., 1994), Madrid (Anchuela et al., 1994; de la Fuente
et al., 1994), and in Edinburgh prior to about 1991 (Robertson
et al., 1986).
These studies also provided an indication of the extent and fre-
quency of HIV risk behaviour among IDUs, particularly concern-
ing the continued use of shared injecting equipment and what
were considered relatively high levels of unprotected sex among
IDUs (Kokkevi et al., 1992; van den Hoek et al., 1992; de la
Fuente et al., 1994; Rezza et al., 1994; Talyor et al., 1994; Davoli
et al., 1995; Malliori et al., 1998).
Yet the contribution of epidemiology to understanding the distri-
bution and determinants of HIV-related risk and disease was
quickly found to be complicated by HIV infection being a behav-
ioural disease (Stimson, 1990).
Of all ‘risk factors’ relevant to mapping the dynamics of HIV
infection among IDUs, one of the most important is ‘risk behav-
iour’, particularly the shared use of injecting equipment and
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unprotected sex. If the factors influencing HIV transmission were
to be understood, it was apparent that the focus of research had
to embrace the variety of individual, social and environmental
factors which influenced IDUs’ ‘risk behaviours’ (Roig Traver et
al., 1987; McKeganey and Barnard, 1992a; Grund, 1993). This
clearly required more than the mapping of viral spread among
individuals and populations designated ‘at risk’, but also
demanded the need to know how a variety of behavioural and
contextual factors interacted to determine why and how injecting
drug use and risk behaviours occurred (Romaní, 1991; 1992;
Gamella, 1993; 1994; Rhodes, 1995; 1997).
Furthermore, in the first instance, little was known about HIV-
related risk behaviours among IDUs. Little attention had been
paid to the processes influencing, or the methods of, drug injec-
tion. Prior to the mid-1980s, there was hardly any published
research describing the shared use of needles, syringes or other
injecting equipment (Howard and Borges, 1970). It therefore
became necessary to observe such practices in the natural set-
tings in which they occurred and to describe them from the per-
spectives of drug users themselves. As shall be seen in the next
three sections of this book, from the mid-1980s onwards, qualita-
tive descriptions of risk behaviour have played a key role in
informing epidemiological measures of HIV risk as well as focus-
ing the attention of researchers and interventionists on the ‘social
meanings’ and ‘social contexts’ of risk behaviour.
THE TIME OF WRITING
The public health imperative to reduce the risk of HIV associ-
ated with drug injecting has brought about renewed interest in
qualitative research on drug use in some countries, and a recog-
nition of the possibilities of qualitative research for the first time
in others.
While an established tradition of qualitative research on drug use
existed, to a varying degree, before the time of AIDS in the United
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States, the Netherlands and the UK, this was not the case in many
European countries.
In addition to increased interest in Germany (Noller and Reinicke,
1987; Noller, 1989; Kemmesies, 1995), Spain (Romaní, 1992;
Gamella, 1993; 1994; 1997a; Pallares, 1996) and France (Coppel
et al., 1990; Boullenger et al., 1991; Tellier and Sobel, 1994; Ingold,
1996; Ingold and Toussirt, 1997; Lert and Lert, 1998), there is
emerging evidence of qualitative studies on risk behaviour associ-
ated with drug injecting in Belgium (Grieten, 1994; Delor, 1997)
and Ireland (O’Gorman, 1998). Taken together, there is evidence of:
• established interest in qualitative research on drug injecting in
the Netherlands and the UK;
• increased interest since the mid-1980s in Germany, Spain and
France; and
• emerging interest since the early 1990s in Belgium, Ireland,
Italy and Portugal.
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FIGURE 5: QUALITATIVE RESEARCH ON HEALTH RISKS ASSOCIATED
WITH INJECTING DRUG USE
Country Established Increased Emerging Scant
Belgium
Denmark
Germany
Greece
Spain
France
Ireland
Italy
Luxembourg
Netherlands
Austria
Portugal
Finland
Sweden
United Kingdom
There is currently scant evidence of published qualitative research
on the risks associated with intravenous drug use in Denmark,
Greece, Luxembourg, Austria, Finland or Sweden (Figure 5).
More recently, interest has shifted from an almost exclusive focus
upon the risks associated with HIV infection towards a broader
consideration of health risks associated with drug injecting. IDUs
may face a variety of health problems related to their drug use. In
particular, the blood-borne viruses hepatitis B and C are prevalent
among IDUs in most EU countries (EMCDDA, 1999a), while
other everyday health risks associated with drug injecting include
secondary infections and vein damage associated with the injec-
tion of ‘non-injectable’ drugs (such as physeptone tablets and
temazepam) and impurities contained within drug solutions. Such
practices increase the likelihood of septicaemia, abscess, throm-
bosis and endocarditis.
In addition, there is a growing interest in qualitative studies examin-
ing IDUs’ experience and management of overdose (Kemmesies,
1995; Rhodes, 1995; Neale and McKeganey, 1997). This reflects
the fact that overdose is one of the most important risk factors in
mortality among IDUs in Europe. The multiple adverse health
consequences associated with drug injecting have led to a focus
in qualitative research on the health lifestyle contexts of IDUs
more generally, and of how the lifestyle context influences prox-
imity to risk.
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INTRODUCTION
At its most fundamental, qualitative research on drug use can be
envisaged as a means of understanding the lived experiences and
meanings of drug use from the perspectives of drug users them-
selves. Additionally, as a means of understanding action as
socially organised, qualitative research aims to understand how
the lived experiences and meanings associated with drug use are
influenced by different social, cultural and economic contexts.
At the outset, qualitative research aims to describe the ‘context-
based’ nature of drug use and the social meanings such behav-
iours are perceived to have. Qualitative research thus proceeds
on the assumption that it is possible to gain an insight into the
factors producing social behaviour, primarily through engaging
with participants themselves (Goffman, 1961; Denzin, 1970;
Agar, 1980). The aim is to describe ‘how individuals perceive,
construct, and interact within their social and economic environ-
ment’ (James, 1977, p. 180).
RESEARCHING HIDDEN POPULATIONS
Conducting research among ‘hidden’ populations has implications
that are at once methodological and practical. Illicit drug use is a
‘hidden’ activity and, in most countries, the majority of drug users
remain hidden from treatment and agency-based services.
Those in contact with services are often unrepresentative of the
broader population of drug users, and this may be the case with
regard to patterns of drug use, risk behaviour and health status.
This has led researchers to consider research methods and sam-
pling designs capable of reaching ‘hidden populations’ whose
‘membership is not readily distinguished or enumerated based on
existing knowledge and/or sampling capabilities’ (Wiebel, 1990,
p. 6).
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Trust and rapport are also critical when attempting to reach those
who ‘live on the margins of a society that is hostile to them’
(Bourgois, 1995, p. 13). Wiebel (1990, p. 5) notes that qualitative
research is often ‘the only means available for getting sensitive and
valid data from otherwise elusive populations’. Qualitative meth-
ods, as the historical description of North-American ethnography
in the previous chapter emphasised, are ideally placed for provid-
ing rich descriptions of hidden populations and behaviours:
‘By design, ethnography is a methodology that incorpo-
rates rapport-building, self-disclosure, non-judgmental sen-
sitivity, genuine concern with the insider’s perspective and
experience, and involvement in the lives of study partici-
pants into its approach and data collection.’ (Singer, 1999,
p. 32).
In addition to drug ethnographies, qualitative sampling methods
have proved invaluable for conducting community-based surveys
of drug use. Overcoming problems of access, recruitment, bias and
trust has encouraged considerable methodological innovation in
sampling and research design (Lambert, 1990; Carlson et al., 1994;
Council of Europe, 1997; Sifaneck and Neaigus, forthcoming). A
key characteristic of such innovation is the use of ethnographic
theoretical sampling techniques emphasising inductive approaches
to the targeted social network; these would include snowball, pur-
posive, and quota sampling (Biernacki and Waldorf, 1981; Kaplan
et al., 1987; 1990; Carlson et al., forthcoming).
In the absence of pre-existing or ‘representative’ sampling frames,
sampling methods in surveys of drug use largely utilise data from
multiple sources in order to target theoretically driven quotas of
drug users and/or social networks using a variety of ‘chain-
referral’ techniques (Biernacki and Waldorf, 1981; Cohen, 1989;
Diaz et al., 1992; Hendriks et al., 1992). Emphasising theoretical
and methodological realism over scientific idealism, such
approaches commonly use ethnography to inform the develop-
ment of numeric sampling quotas in particular geographical or
social environments, as well as in participant recruitment and 
follow-up (Carlson et al., forthcoming).
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The use of ethnographic fieldworkers and key informants, includ-
ing those with ‘indigenous’ or ‘privileged’ access, has become a
common feature of such designs, aiming to maximise access and
rapport as well as ethnographic description (Hughes, 1977; Hen-
driks et al., 1992; Griffiths et al., 1993; Power, 1995). While the
use of snowball-sampling methods borrows from ethnographic
methods, particularly as far as gaining access, rapport and inform-
ing sampling design is concerned, such studies need not be
‘ethnographic’ in the data they collect or in the analyses they
undertake. However, qualitative sampling methods have become
key features of quantitative studies of drug use (Biernacki and
Waldorf, 1981; Carlson et al., 1994; forthcoming).
UNDERSTANDING
THE EXPERIENCE OF DRUG USE
Behaviours communicate social meanings. Two key tenets of
qualitative research are to describe the social meanings partici-
pants attach to drug use experiences and the social processes by
which such meanings are created, reinforced and reproduced
(Moore, 1993; Rhodes, 1995; Agar, 1997).
Illicit drug use is a social activity, and the process of drug-taking
derives symbolic importance, and has social meaning, depending
on the contexts of use (Becker, 1953; Grund, 1993). Qualitative
research is therefore concerned with descriptions of how drug use
is ‘lived’ and interpreted through social interactions.
Whereas epidemiological research concentrates on delineating
the distribution of patterns of drug use and its consequences,
qualitative research aims to appreciate why and how such behav-
iours occur (Rhodes, 1995).
Due to their inductive and iterative approach to data collection
and hypothesis generation (Znaniecki, 1934; Layder, 1993), qual-
itative methods are ideally suited to describing the ‘lived experi-
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ence’ of drug use from participant perspectives. Whereas deduc-
tive designs, as well as most quantitative research, tend to be
construct-driven — defining categories or variables of interest a
priori on the basis of pre-existing hypotheses and theoretical
frameworks — inductive designs aim to construct interpretations
on the basis of data as they emerge from participant descriptions
and observations (Agar, 1980; Layder, 1993).
Figure 6 shows six key stages in an inductive approach. To over-
simplify, the ethnography of drug use is data driven, and thus
hypothesis-generating, leading to the discovery of subjective
meaning, whereas the epidemiology of drug use is construct
driven, and thus hypothesis testing, leading to the charting of
(presumed-to-be) objective measures of drug use.
One of the most incisive examples of how induction led to captur-
ing understandings of drug use based on drug users’ own experi-
ences is Lindesmith’s seminal study ‘Opiate addiction’ (1947). 
Lindesmith based his inductive analysis on his attempt to discover
negative evidence for his emerging generalisations (Silverman,
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• An approximate definition of the phenomenon to be explained is formu-
lated
• A hypothetical explanation of that phenomenon is formulated
• One case is studied in the light of the hypothesis, with the aim of determin-
ing whether or not the hypothesis fits the facts in that case
• If the hypothesis does not fit the facts, either the hypothesis is reformulated
or the phenomenon to be explained is redefined so that the case is
excluded
• Practical certainty may be attained after a small number of cases has been
examined, but the discovery of negative cases disproves the explanation
and requires a reformulation
• This procedure of examining cases, redefining the phenomenon and 
reformulating the hypothesis is continued until a universal relationship
is established, each negative case calling for a redefinition, or a refor-
mulation
Source: Denzin, 1970, p. 195; Silverman, 1985, p. 112.
FIGURE 6: SIX KEY STAGES IN ANALYTIC INDUCTION
1985). Using such an approach, Lindesmith discovered that the
experience of opiate addiction had a social rather than merely
physiological basis (Lindesmith, 1947). His original hypothesis had
been that addiction was associated with a knowledge of the drug
being used and a sufficient history of use to produce withdrawal
effects. However, the discovery of negative cases led Lindesmith to
reformulate his hypothesis to one which related addiction, not 
to withdrawal distress per se, but to the use of the drug after 
withdrawal had occurred for the purposes of alleviating perceived
distress (Silverman, 1985, p. 112). No negative cases to this revised
hypothesis were found, and the conclusion was reached that an
‘addict’s craving for opiates is born in his experience of relief of
withdrawal’ (Lindesmith, 1968, p. 100):
‘Addiction rests fundamentally upon the effects which fol-
low when the drug is removed, rather than on the positive
effects which its presence in the body produces ... If the
individual fails to conceive of his distress as withdrawal
distress brought about by the absence of opiates, he cannot
become addicted.’ (Lindesmith, 1947, p. 165).
What Lindesmith termed the systematic search for a ‘decisive neg-
ative case’ (Silverman, 1985), in order that his emerging hypothe-
ses were ‘grounded’ in his data, led to him proposing what was
probably the first definition of addiction ‘derived from ethno-
graphic research’ (Feldman and Aldrich, 1990, p. 18). Lindesmith
had proposed a ‘social theory’ of addiction based on drug users’
experiences. Adopting an inductive approach had led to the dis-
covery of the unexpected. Addiction was no longer merely consid-
ered a product of ‘dependence-producing’ drugs but of whether
and when drug users stopped using drugs (Singer, 1999):
‘The failure of addicts to “kick the habit” permanently is
doubtless tied up with their reluctance to abandon old
associates and a familiar environment. The use of drugs is
much more than a biological matter or a mere question of
pharmacology.’ (Lindesmith et al., 1975, p. 571).
While most contemporary qualitative studies on drug use are
inductive, they also tend to be open to pre-existing empirical dis-
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coveries as well as to policy directives. The analyses they pro-
duce are rarely limited by the empirical discoveries made within
the study but are most likely to be guided by them in the context
of other forms of knowledge (Layder, 1993).
This is a more ‘open’ approach to grounded analysis than that
championed by the grounded theory approaches proposed by
Glaser and Strauss (1967) and is better suited to studies which
prioritise producing findings of policy relevance over generating
formal theories of addiction or risk behaviour. More recent stud-
ies, for example, have shown the value of inductive approaches
in understanding needle and syringe sharing and the varying
social meanings attached to such behaviours by IDUs (Murphy,
1987; Zule, 1992; Grund, 1993; Koester, 1996).
UNDERSTANDING THE SOCIAL CONTEXTS
OF DRUG USE
The social meanings of behaviours are context-dependent. As has
been noted, the aim of qualitative research is to understand the
nexus of ‘meaning’ and ‘context’ (Agar, 1995; 1997). Here, the
role of qualitative research is to distinguish how drug use pat-
terns, and their meaning and interpretation, differ by social, cul-
tural and economic context. The ‘social context’ of drug use is
made up of an interplay of factors, including:
• individual and group subjective interpretations of drug use;
• the physical, interpersonal and social settings in which drug use
occurs; and
• wider structural and environmental factors.
Building on notions of social interactionism — the study of how
the social meanings of behaviour are created and reinforced
through social interaction itself (Denzin, 1970) — ‘social context’
is viewed as a key process influencing how the meanings and prac-
tices of drug use are ‘socially organised’ (Becker, 1963; 1970).
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A variety of studies have illustrated how individuals’ beliefs and
interactions associated with drug use are influenced by context.
The meanings and practices of needle and syringe sharing, for
example, have been found to depend on:
• the influence of perceived social or network norms and expec-
tations (Power et al., 1996; Rhodes and Quirk, 1996; Wiebel,
1996);
• particular interpersonal and social relationships (Zule, 1992;
Barnard, 1993a);
• the physical and social settings in which drug use occurs (Ouel-
let et al., 1991; Ruggiero, 1992; Turnbull et al., 1996; Wiebel,
1996); and
• wider structural, economic and policy factors (Murphy, 1987;
Pearson, 1987; Grund et al., 1992a; Gamella, 1994; Bourgois,
1997).
A number of European studies have illustrated how the micro and
macro settings in which drug use occurs influence patterns of
drug use and drug-using lifestyles, as well as the health and social
risks related to drug use (Arlacchi and Lewis, 1990a; 1990b; 
Ruggiero, 1992; Bless et al., 1995; Kemmesies, 1995; Blanken et
al., 1996).
Studies by Pearson (1987), Gamella (1994; 1997a) and Fraser and
George (1988), for example, show how exogenous factors —
such as policing, housing, and heroin availability — influence the
social relationships maintained or lost within particular geograph-
ical or social networks, which, in turn, influence patterns of pur-
chasing and dealing and the diffusion of new drug trends. Of key
interest here is the dual importance of social relationships in
mediating initiation and use and the influence of macro-
contextual factors in creating or sustaining social relationships
conducive to drug use (Pearson, 1987; Gamella, 1994).
In quite a different study, Henderson (1996) describes how pat-
terns of ecstasy use are, to a large extent, ‘socially organised’
within the social mores of rave and dance club cultures. Like
Becker’s work on LSD and marijuana (Becker, 1953; 1970), she
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finds that the behavioural manifestations of the effects of ecstasy
are contained within this particular context. Other studies high-
light particular cultural beliefs or ‘subcultures’ as important deter-
minants of belief and perception associated with drug use, its
effects and associated risks (Noller and Reinicke, 1987; van
Gelder and Sijtsma, 1988; Noller, 1989). The social contexts of
drug use mediate the social meanings and practices of drug use.
Qualitative research, therefore, has a pragmatic contribution to
make to the development of interventions and policies consistent
with ideas of social and environmental change.
INFORMING QUANTITATIVE RESEARCH
A well-established role of qualitative research is to inform the
design of quantitative measures of drug use. Here, qualitative
research aims to inform the development of meaningful con-
structs or measures in quantitative studies, as well as to shape
appropriate analyses and their interpretation (Wiebel, 1990;
1996). The identification and interpretation of injecting risk
behaviours associated with HIV transmission provides an obvious
example.
As will be discussed in the next section, the practices of ‘front-
loading’, ‘back-loading’ (see pages 59–61) and other methods of
‘indirect’ sharing were identified on the basis of direct observa-
tions of drug injecting in Rotterdam (Grund et al., 1990; 1991).
Similarly, ethnographic observations in Denver and El Paso iden-
tified a variety of other ‘indirect’ sharing practices at the time pre-
viously unexplored (Koester et al., 1990; Koester and Hoffer,
1994; Koester, 1996; Wiebel, 1996). In many cases, drug injec-
tors were found to be unwittingly engaging in HIV-related risk
behaviours (Wiebel, 1996).
In addition to identifying drug-use behaviours or theoretical con-
structs for subsequent epidemiological measurement, qualitative
data play a key role in interpreting the findings generated by
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quantitative research. It has been demonstrated, for example, that
data from qualitative interviews may be used to help interpret and
substantiate the findings of quantitative surveys and statistical
models (Barnard and Frischer, 1995). While statistical modelling
may identify correlational relationships between variables, it does
not adequately assess why or how these relationships exist or
explain what these associations mean. The triangulation of multi-
ple methods and data sources, and the combined use of quantita-
tive and qualitative methods in particular, enables the researcher
to cross-check findings in order to increase the validity of inter-
pretations (Denzin, 1970).
QUESTIONING QUANTITATIVE RESEARCH
As a complement to epidemiological research, which tradition-
ally centres on the interplay between ‘agent’, ‘host’ and ‘environ-
ment’, qualitative research has been described as an attempt to
provide a better understanding of how ‘host’ interacts with 
‘environment’ (Agar, 1997).
Qualitative interpretations of the meaning and context of drug use
are crucial for informing epidemiological studies. This has led
towards developing ‘ethno-epidemiologies’ of drug use (Agar,
1995; 1997). These ethno-epidemiologies involve attempts to bet-
ter situate epidemiological measures and analyses within ‘partici-
pant’ rather than ‘outsider’ frameworks of interpretation, as well
as to encourage paradigm shifts in contemporary epidemiology
away from an over-emphasis on ‘risk factor’ approaches towards
emphasising the social–environmental determinants of drug use
(Agar, 1995; Pearce, 1996; Susser and Susser, 1996).
As Agar indicates: ‘ethnography isn’t just a methodological add-
on; it is a conceptual and theoretical means to a necessary epi-
demiological end’ (Agar, 1997, p. 1166). In this respect, ethnog-
raphy and epidemiology converge, where the ‘failures’ of modern
risk-factor epidemiology (Susser and Susser, 1996) encourage a
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realisation of the need for epidemiological constructs to be ethno-
graphically explored as well as for ethnography to inform the
development of epidemiological measures:
‘The first need is to restore “host” and “environment” to
central importance in epidemiological analysis, to defocus
on “agent” and celebrate the two other corners of the epi-
demiological triad. From “host” it isn’t difficult to derive a
focus on “meaning”, for it is a truism that human hosts live
in a symbolic and material world. And it isn’t difficult to
arrive at “context” from “environment”, since a concern
with context reveals the layers of circumstance, ranging
from immediate situation to political economy, in which
the “hosts” shape their lives. The need to restore the impor-
tance of host and environment, then, requires the study of
meaning and context. And the investigation of meaning
and context is exactly the research task that ethnography is
designed to accomplish.’ (Agar, 1997, p. 1166).
There is general consensus that quantitative methods can learn
from qualitative methods, as well as vice versa, and that such
methods provide a set of complementary tools to investigation
(Hartnoll, 1995). There is agreement that ‘methodological iden-
tity’ should not be preserved at ‘the cost of greater understanding’
(McKeganey, 1995). However, the longstanding ‘divides’ between
‘qualitative–inductive’ and ‘quantitative–deductive’ approaches
maintain for a reason. Every method, to some extent, shapes the
findings it produces. Yet qualitative methods are arguably better
suited to questioning deductive modes of explanation than the
other way round (Pearson, 1995). Quantitative–qualitative differ-
ences are helpful if all methods are appropriately applied to the
research question in hand and if each can be scientifically critical
of the other (Hartnoll, 1995; Pearson, 1995).
An ethnographically informed epidemiology of drug use is a chal-
lenge which continues to escape most drugs research, and few
contemporary epidemiological studies of drug use either attempt
or adequately achieve an understanding of drug use in its 
environment (ACMD, 1998).
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An important role played by qualitative research, therefore, is that
it has the potential to question the application and interpretation
of a priori epidemiological constructs, as well as the logic of
deductive research (Moore, 1993; Rhodes, 1995; 1997; Bloor,
1997; Romaní, 1997). This is particularly important, given the
considerable resistance to paradigm shifts within epidemiology
and the paradigm predominance of positivism more generally
(Susser and Susser, 1996).
The tenets of induction and hypothesis-generation encourage
analyses grounded in the perspectives of participants, of which
the researcher is one. Qualitative research is both iterative and
reflexive (Moore, 1993). In adopting a different epistemiological
logic to the deductive approach, it both complements as well as
challenges the assumed objectivity of common sense understand-
ings of drug use. Induction enables the discovery of plural — and
competing — interpretations of drug use and addiction which
often fall outside the interpretative frameworks championed by
positivist and conventional epidemiological research.
As Moore has noted of his ethnography of recreational drug
use, whereas dominant research and policy discourses talk of
‘drug-related ‘problems’ and ‘harm’ and how to reduce their
incidence’, participants were found to emphasise the ‘benefits’
of drug use in their ‘talk of “big nights” and “speeding”’
(Moore, 1993, p. 17). Studies oriented to explorations in ethno-
epidemiology have illustrated how ‘drug use’, ‘addiction’ and
‘problems’ associated with drug use are, in part, socially
constructed by the paradigms, methods and findings of research
(Grund et al., 1993; Bloor, 1997). Qualitative methods are, of
course, not immune from this process (since all acts of research
are forms of interpretation), but they aim to be reflexive about
the process of interpretation and do not blindly purport to
capture objectivity.
It is important to reiterate that drug users are the experts on their
lived experiences of drug use. No research method or design
has the capacity to capture objective empirical ‘facts’, and it is
pretence or rhetoric which says otherwise (Moore, 1993). 
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A divide remains between applied qualitative and quantitative
research in the drugs field (Heath, 1995; McKeganey, 1995;
Pearson, 1995). Qualitative methods are undervalued, and rarely
reach their potential, because they are commonly envisaged as
a mere complement or supplement to positivist research (which
is viewed as producing ‘hard’ or objective facts and as ‘real
science’).
The challenge for the future clearly involves the use of multiple
methods in drugs research and this also requires recognition of
the paradigmatic differences underpinning induction and deduc-
tion. Not only is there a need to ground epidemiology within par-
ticipant interpretative frameworks of what is meaningful, but
there is an equal need to realise the contribution of qualitative
research in questioning ‘expert’ understandings, the discourses of
drug use within which they operate, and their perpetuation by an
over-reliance on positivist paradigms.
DEVELOPING EFFECTIVE RESPONSES
The pivotal role of qualitative research in informing the design of
drug interventions and policies is twofold. First, it is important to
target interventions in cognisance with local drug use norms and
practices. This also demands an appreciation of how different
social and economic contexts influence drug use, as well as the
drug user’s capacity for initiating and sustaining behaviour
change. Second, an understanding of the social processes shaping
everyday drug use is a necessary prerequisite for developing
interventions which are meaningful and useful to drug users
themselves. A wealth of research highlights the pragmatic contri-
bution of qualitative research to intervention and policy develop-
ment, particularly with regards to the design and evaluation of
community-based initiatives (Hughes, 1977; Feldman and
Aldrich, 1990; Brooks, 1994).
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In keeping with the multiple roles of qualitative research summarised
above, ethnographic contributions to drug intervention develop-
ments, including policy, have emphasised the importance of:
• understanding drug users’ perceived needs for, and experiences
of, interventions;
• understanding service providers’ perceptions of service need,
organisation and effectiveness; and
• exploring the social and contextual processes influencing the
effectiveness of intervention delivery and impact (as with qual-
itative process evaluation).
Examples have included treatment ethnographies exploring drug
users’ experiences of methadone and other forms of drug treatment
(Preble and Miller, 1977; Korf and Hoogenhout, 1990; Keene and
Raynor, 1993; Rosado and Escursell, 1994; Lilly et al., forthcom-
ing); help-seeking and service utilisation (Hartnoll and Power,
1989); general practice (McKeganey, 1988); health promotion and
community interventions (Jamieson et al., 1984; Boullenger et al.,
1991; Rhodes et al., 1991; Brooks, 1994; Grieten, 1994; Sheridan
and Barber, 1996; Shiner and Newburn, 1996); responses to policy
(Grund et al., 1992b; Agar, forthcoming); developing links
between ethnography and community outreach (Hughes, 1977;
Sterk, 1993; Wiebel, 1996); and understanding the impact of
prison settings on drug use (Turnbull et al., 1996).
Here, then, qualitative research is viewed not as a means of
knowledge generation for its own ends but as a means of ‘action-
oriented’ research and intervention development (Coppel and
Touzeau, 1988; Power, 1995; Stimson et al., 1999). The increas-
ing receptivity to the use of qualitative methods is less indicative
of wider paradigm shifts in method than it is an outcome of the
realisation that qualitative research has immense practical utility
for developing local responses to drug use (Feldman and Aldrich,
1990; Wiebel, 1996). This has led to developing models of qual-
itative ‘action-research’ (Coppel and Touzeau, 1988; Coppel et
al., 1990; Power, 1995) and of ‘rapid assessment and response’
using multiple qualitative methods (Rhodes et al., 1999c; Stimson
et al., 1999).
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The development and evaluation of effective responses requires
an understanding of the interplay between the meaning and con-
text of drug use as well as of intervention need, feasibility and
appropriateness. Qualitative research is ideally positioned to pro-
vide the data necessary for evidence-based practice.
MULTIPLE ROLES, MULTIPLE METHODS
The challenge for future drugs research is to recognise the prag-
matic utility and methodological desirability of using multiple
methods in order to encourage research which understands the
epidemiology and the social context of drug use. Separating out
inductive/deductive and qualitative/quantitative approaches is
neither helpful nor appropriate in developing understandings of
the interplay between individual, social and contextual factors
influencing drug use (Agar, 1995; 1997). Each are different but
both are required. Neither the ethnographer nor the survey
researcher alone necessarily produces the data required to yield
width and depth (Hammersley, 1992). Additionally, single-
method studies run a higher risk of bias. More than this, they may
be unaware of bias; of how the methods of data collection and
analysis shape the findings produced. Every method reveals and
conceals different aspects of the phenomena under study. A fun-
damental principle underpinning modern social science is there-
fore the use of multiple methods (Denzin, 1970).
In conclusion, there must be multiple roles for qualitative
research in understanding and responding to drug use. We may
view qualitative methods as a complement to quantitative
methods, and may emphasise that all methods are tools for
capturing different aspects of drug use and its consequences.
The challenge for future drugs research is to enlist qualitative
methods as fundamental components of multi-method studies of
drug use. Qualitative methods, and more generally, inductive
designs, complement their quantitative and deductive counter-
parts in capturing the interplay between the meanings and
contexts of drug use.
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If one challenge for future drugs research is to realise the oppor-
tunities afforded by multiple methods, a second challenge is to
recognise the importance of developing ‘ethno-methodological’
studies of drug use (Agar, 1997). The need for multiple methods
does not deny the differences between inductive and deductive
designs; it uses such differences to aid interpretation and
response. Qualitative research has an additional role to play: in
questioning or challenging ‘common-sense’ interpretations of
drug use that are often unwittingly reinforced and reproduced by
positivist paradigms.
Seminal drug ethnographies of the past — such as Lindesmith’s
study, ‘Opiate addiction’ (1947) — point to the importance of
generating ethnographically informed rather than a priori
imposed understandings of drug use. In the absence of qualitative
research, there is a danger of perpetuating understandings of drug
use which are devoid of relevance or meaning for drug users.
This, in turn, can encourage the formation of policy or the devel-
opment of interventions which are inappropriate or ineffective
and, at worst, counter-productive.
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SHARING INJECTING EQUIPMENT
Encouraging a reduction in needle and syringe sharing is a cor-
nerstone intervention of public health strategies targeting IDUs in
most EU countries (EMCDDA, 1999a). Surveys associate syringe
distribution, exchange and availability with declines in levels of
needle and syringe sharing and reduced risk of HIV transmission
(Hunter et al., 1995; Hurley et al., 1997; Des Jarlais et al., 1998).
A key qualitative research question, however, is why, and under
what circumstances, does sharing continue to occur? Even a
glance through the existing research literature highlights an
interplay of individual, social and material factors associated
with needle and syringe sharing. The act of sharing a syringe is
not merely dependent on individuals’ risk awareness and
perceptions, but on a variety of social and contextual factors
influencing needle and syringe availability, social norms with
respect to drug use practices and the interpersonal negotiation of
risk behaviour and reduction (Murphy, 1987; Grund et al.,
1992a; Koester, 1994; Hurley et al., 1997). If interventions are to
encourage further reductions in needle and syringe sharing
among IDUs, there is a need to take account of how different
social situations and contexts impinge on, or encourage,
attempts at risk reduction.
The first task facing qualitative researchers of HIV-related risk
behaviour among IDUs was to describe and define sharing prac-
tices. While epidemiological evidence had identified needle and
syringe sharing as one of the most important risk factors mediat-
ing HIV transmission among IDUs (Oppenheimer, 1992), little
was known about IDUs’ sharing practices except for a relatively
obscure study on needle sharing in San Francisco (Howard and
Borges, 1970). At this time, the reasons why IDUs shared inject-
ing equipment, beyond reasons of general unavailability, was
something of a mystery. By the late 1980s, it had become the task
of observational and interview studies to discover the circum-
stances in which sharing took place, the factors motivating it, and
its frequency and extent.
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DESCRIBING SHARING PRACTICES
Qualitative studies have highlighted the diversity and complexity
of ‘sharing’ practices. Perhaps the most incisive studies in this
respect are those undertaken by Grund and colleagues in Rotter-
dam, and Koester and colleagues in Denver (Grund et al., 1990;
1991; 1993; 1996; Koester et al., 1990; Koester and Hoffer, 1994;
Koester, 1996). Between them, these studies systematically
‘unpacked’ multiple forms of ‘syringe-mediated drug sharing’
(Grund et al., 1996). As Koester said of his observational studies
on injecting drug use:
‘… the ethnographer learns by being there, by seeing what
people do, by listening to what they say, and by experi-
encing at first hand the factors that influence their lives.’
(Koester, 1996, p. 133).
Based on a series of observations of how IDUs go about mixing,
dividing, distributing and injecting drug solutions, Koester and
Hoffer identified nine distinct types of injecting equipment sharing
in addition to directly sharing a previously used needle or syringe.
As listed in Figure 7, these practices, each of which may carry a
risk of transmitting blood-borne viruses, included the shared use
of rinse water, cookers, mixers and cotton filters, as well as ‘front-
loading’ and ‘back-loading’. They termed these practices ‘indirect
sharing’, to distinguish them from the ‘direct use of a single
syringe by two or more IDUs and to suggest their more masked
character’ (Koester, 1996, p. 135). These findings encouraged
Koester to reach the following conclusion:
‘With the inclusion of ethnographic research as an integral
component of HIV epidemiology, our understanding of
both syringe sharing and these other potential injection-
associated risks has increased significantly ... Ethnographic
research on the process of drug injection has revealed a
range of injection-associated practices that may place
IDUs at risk of HIV even when they use their own syringes
to inject.’ (Koester, 1996, p. 145).
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Koester’s studies in Denver illustrate the critical role of quali-
tative research in describing behaviours which are potentially
risky with respect to the transmission of HIV and hepatitis B or
C virus infection. Without such rich description, it is possible
that epidemiologically derived definitions of transmission risk
may lack the specificity required to adequately capture the
nuances and complexity of risk behaviour. This point is rein-
forced when one considers the ethnographic discovery of
‘front-loading’ and ‘back-loading’. While both are included in
Koester and Hoffer’s typology of ‘indirect sharing’ practices,
these were identified some years earlier on the basis of a series
of 95 observations with approximately 192 IDUs in 14
different houses or squats in Rotterdam (Grund et al., 1990;
1991).
Grund noted that approximately 80 % of observed sharing occa-
sions involved what he termed ‘streepjes delen’ or ‘front-loading’
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• Rinsing previously used syringe(s) in a shared water container prior to
drug preparation and injection
• Using one participant’s syringe to draw up water for dissolving the drug
• Using the rubber internal end of a participant’s syringe plunger to mix
water with the drug
• Using one participant’s syringe to measure and distribute a share of the
drug solution to each participant (distribution then occurs through
‘back-loading’ or ‘front-loading’)
• Drawing each share of the drug through a common cotton filter
• Returning the drug solution to the common cooker, or directly to
another injector’s syringe when an injector inadvertently draws up
more than his/her share
• Returning the drug solution to the cooker or directly into another’s
syringe to ‘kick them out a taste’
• ‘Beating a cotton’ that others have placed their needles in to draw up
their dose
• Rinsing a used syringe in water in which others have previously placed
used syringes for mixing and rinsing
Source: Koester, 1996, p. 135.
FIGURE 7: ‘INDIRECT SHARING’: AN ETHNOGRAPHIC TYPOLOGY
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(Grund et al., 1991). This is where a single preparation of a drug
solution is shared equally by loading the solution from one
syringe barrel directly from the front of another (its needle having
been detached).
‘Back-loading’ is this process in reverse, where the solution from
one syringe is injected into the back of another (its plunger hav-
ing been removed). These ethnographically defined practices
soon entered the battery of epidemiological measures of injecting
risk behaviour and associated HIV transmission (Samuels et al.,
1992; Jose et al., 1993). A description of ‘back-loading’ based on
observation field notes is contained in Figure 8.
Ethnography has played a critical role in informing, refining
and questioning epidemiological measures of risk behaviour.
More recent examples concern the identification of HIV risk
practices associated with the distribution and production of
liquid opiate drugs in parts of eastern Europe (Rhodes et al.,
1999b). The most commonly injected opiates in the Ukraine,
for example, are kitchen-based domestically produced deriva-
tives of poppy straw, often termed ‘chornyi’ (black) or ‘khimiya’
(chemistry). Liquid ‘amphetamine-like’ drugs, known as ‘vint’
(screw) or ‘belie’ (white), are also domestically produced from
ephedra (which grows wild) or ephedrine (extracted from cough
syrup).
The drug solution is in one of the insulin syringes. She pulls the plunger
out of the other syringe and holds the barrel almost horizontal. Slowly,
she squirts half of the solution into the back opening. ‘You need to do it
very precisely. It must not go in all the way, otherwise you fuck up.’ Just
as she explains, the liquid accumulates about 1 cm from the back of the
needle. She puts down the donor syringe, picks up the plunger and
carefully holds it against the opening. In one smooth movement she
pushes the plunger a little into the barrel, while simultaneously turning
the needle upwards. ‘This is the crucial move,’ she explains. ‘I’ve seen
several people blow shots doing it, squirting the shot into the air. Mostly
when they were sick, shaking hands, you know.’
Source: Grund et al., 1996, p. 693.
FIGURE 8: ‘BACK-LOADING’, AS OBSERVED IN A NATURAL SETTING
Observations in Russia and the Ukraine point to the possibility of
HIV entering the production process via containers and mixers
used to collect, decant and mix the solution ingredients (which
may include industrial solvent, acetic anhydride, vinegar, soda,
water) (Burrows et al., 1998).
Additionally, the rapid spread of HIV in some eastern European
countries may be associated with the methods by which drug
solutions are distributed (Rhodes et al., 1999b). In Russia and the
Ukraine, two common methods include the distribution of drug
solutions in ready-filled syringes (consumers purchase the ready-
filled syringe), and the distribution of solutions via ‘front-loading’
directly from a dealer’s donor syringe (dealers may carry 10 or
20 ml syringes and/or separate containers of solution from which
to refill donor syringes). These modes of distribution may be influ-
enced by local environmental factors, including:
• geography (where drug production and distribution sites are
separate);
• ease of transit of drug solutions to distribution sites;
• the need for rapid transactions between consumers and dealers;
and
• ease of measurement of the amount of distributed solution.
Taking these examples together, one can appreciate that qualita-
tive descriptions of the processes of drug production, preparation,
distribution and injecting are of crucial importance in developing
sensitive measures of risk.
FUNCTIONS AND MEANINGS
While epidemiological studies note the potential HIV transmis-
sion risks of indirect and direct sharing practices, they may fail to
adequately capture their functional or social dimensions. Such
practices are often habituated as part of the ‘everyday’ routines of
drug injection, and are situated within the specific contexts in
which injecting occurs.
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First, sharing practices are functional. Principal here is the ‘need
to cope with one’s craving for drugs’ in a context of scarce or
inadequate availability of clean injecting equipment (Mata and
Jorquez, 1991).
Figure 9 shows a number of contextual factors commonly associated
with needle and syringe sharing by IDUs, including withdrawal. As
Grund and colleagues have noted of front-loading in Rotterdam, it
serves an ‘instrumental function in preventing withdrawal’:
‘“Helping” with a betermakertje (a little dose to ameliorate
withdrawal) is a common motivation for drug sharing. The
term “helping” is an everyday expression referring to the
revered rule of aiding a fellow user who is in withdrawal.
Likewise, drugs are frequently brought together and subse-
quently shared by front-loading.’ (Grund et al., 1993, p. 80).
Second, qualitative studies illustrate that the sharing of drug solu-
tions and injecting equipment is more than pragmatic or eco-
nomic, since these practices are embedded within a wider social
dynamic of behaviours which are responsive to shared rules and
norms in drug-user relationships. Sharing also functions as a sym-
bolic act, influenced by the social functions and meanings such
practices have for participants (Murphy, 1987; Grund et al., 1993;
1996; Gamella, 1994; Grieten, 1994).
Principal among these is the communication or display of reci-
procity and trust within social relationships (McKeganey and
Barnard, 1992a; Zule, 1992; Barnard, 1993a). Ethnographic work
on ‘indirect sharing’, for example, has shown that the social val-
ues or meanings attached to such activities range from the trust
and assurance gained from the equal sharing of drug solutions 
(as with front/back-loading) to the giving and receiving of ‘gifts’
(as with the borrowing of used filters containing residual drug
solution) (Koester, 1996; Power et al., 1996).
Sharing drug solutions or injecting equipment may come to be
collectively viewed as symbolic displays of reciprocity in inter-
personal or group relationships and not merely as pragmatic
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Lack of availability
‘The syringe got really blunt and I couldn’t use it anymore.’
Withdrawal
‘I was ill and in need of some heroin. I would have killed my granny to
get a syringe by that stage.’
Unawareness that the equipment had been used 
‘I took it from his box by accident instead of mine. And it was bloody
open and I bloody used it thinking it was mine.’
Intoxication
‘I was out of control.’
Social proximity to sharing partners
‘If they were someone I didn’t know I wouldn’t have shared.’
Source: Rhodes, Quirk and Stimson, 1995.
ways of dividing up and using drugs. Qualitative studies have
shown that the availability of needles and syringes is an impor-
tant contextual factor but that it is not, in itself, a sufficient
explanation for continued sharing. These studies encourage us to
consider drug-sharing practices as social processes; as
embedded within drug users’ wider social relationships more
generally:
‘Addicts share many valued things such as housing, food,
money, clothing and childcare. Often they help one
another with daily problems associated with the addict life
where sharing fits the broader context of coping with crav-
ing, needs for human contact and the hardships of life on
the margins of society. In this context, the sharing of drugs
serves as a strong symbolic binding force.’ (Grund et al.,
1993, p. 383).
‘Drug sharing is at once a means to socialise, to belong,
and to provide some measure of protection from the exi-
gencies of la vida loca.’ (Mata and Jorquez, 1991).
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FIGURE 9: SOME REASONS FOR NEEDLE/SYRINGE SHARING
That the sharing of drug solutions and injecting equipment has
social meanings for participants highlights that multiple meanings
of ‘sharing’ coexist. Here, the findings of qualitative research have
been particularly instructive for studies of risk behaviour. Not
only has research found that IDUs associate their sharing prac-
tices with meanings other than ‘risk’, they also indicate the inad-
equacy and inappropriateness of commonly applied epidemio-
logical measures of ‘sharing’ (McKeganey and Barnard, 1992a).
A semi-structured interview study undertaken by Shelley and col-
leagues, for example, found that multiple and contradictory inter-
pretations of sharing exist, with some IDUs understanding sharing
only to mean the use of another’s syringe during the same inject-
ing episode. Qualitative work with IDUs on release from prison
has also noted that ‘sharing’ may be temporally defined, with the
use of equipment previously used during a different injecting
occasion viewed as ‘just using old works’ (Turnbull et al., 1996).
SETTINGS AND CONTEXTS
Needle and syringe sharing is not a random activity, but instead
may follow lines of kith and kin. This is clearly evident with
respect to sharing in the context of sexual relationships. While
epidemiological studies have tracked ongoing reductions in the
extent of needle and syringe sharing, qualitative studies have
highlighted that most continued sharing occurs within the context
of long-term sexual relationships, close friends and family
(Barnard, 1993a; Bloor, 1995; Rhodes and Quirk, 1996).
Local conditions of needle availability may influence the preva-
lence of such risk behaviour, but risk behaviours embedded within
the structure of particular social relationships may be difficult to
change, particularly when such change involves challenging the
emotional fabric of relationships (Rhodes and Quirk, 1998). Drug
solution and equipment sharing within the context of sexual rela-
tionships may be perceived as expressive of ‘togetherness’. 
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It is common for qualitative studies to note that sharing with sexual
partners has meaning other than ‘risk’ (McKeganey and Barnard,
1992a; Barnard, 1993a). As IDUs have said of sharing within sex-
ual relationships: ‘It’s not really like sharing, is it?’ (quoted in
Rhodes and Quirk, 1996).
In addition to the particular social relationships influencing risk
acceptability, studies note the importance of particular social and
physical environments. In this respect, North-American research
has focused on sharing within ‘shooting galleries’ (Ouellet et al.,
1991; Wiebel, 1996). Ouellet and Wiebel describe how different
Chicago shooting galleries have their own unique set of organisa-
tional norms or ‘rules’ for the renting out of injecting equipment.
In ‘cash galleries’, the sale or rental of syringes is run like a busi-
ness, where gallery operators establish a formal set of rules and
enforce compliance. In ‘taste galleries’, which usually operate
from an injector’s room or apartment, reciprocity is less for-
malised, and the operator is normally given a small portion, or a
taste, of the drugs in exchange for a safe place to inject or the
equipment borrowed. In ‘free galleries’ (often found in aban-
doned buildings), there is no commodity exchange.
Different gallery environments were found by Ouellet and Wiebel
to impinge directly on individuals’ risk perceptions and behaviour
(Ouellet et al., 1991; Wiebel, 1996). In free galleries, for example,
there was rarely running water available. This meant that contain-
ers of water for mixing, shooting and rinsing were left at gallery
sites. There was, as a consequence, a risk of HIV transmission
through the sharing of contaminated water. Whereas cash galleries
were found to be generally receptive to HIV prevention initiatives,
and often provided bleach, clean water and containers for syringe
disposal as part of the service, many taste galleries were closed
operations which remained inaccessible to health outreach work-
ers. One of the conclusions of this research was that the social con-
text of shooting environments are of crucial importance in under-
standing group risk behaviour norms and practices (Wiebel, 1996).
There has been considerable European interest in the prison ‘risk
environment’. Exploration of the dynamics of sharing in prisons
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has underlined the greatly increased risks of HIV spread (Sueur,
1993; Taylor et al., 1995; Magliona and Sarzotti, 1996; Turnbull
et al., 1996; Bouhnik and Touzé, 1997; Abeni et al., 1998).
As illustrated in Figure 10, qualitative studies have pointed to the
fact that the prohibition of injecting equipment in prison settings
may not deter prisoners from sharing; many may see themselves
as having ‘no choice’ but to share (Turnbull et al., 1996).
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‘He asked me if I wanted some works [needle/syringe] . . . I asked him if
it was a new works, and he went “no”, and he said “there’s only two
people that’s used it”. I went “yeah, all right, forget that”.’
‘I had to sharpen it (the needle) with a matchbox. A needle in there costs
GBP 10. I didn’t have that kind of money.’
‘You’ve got no choice if you’re used to injecting . . . I inject drugs. I have
done for 10 years. You can’t change overnight, especially in there.’
Source: Turnbull, Power and Stimson, 1996, p. 256.
FIGURE 10: PRISON AS A RISK ENVIRONMENT
Qualitative studies of sharing practices within the context of par-
ticular social or sexual relationships, and within particular ‘high-
risk’ environments, provide examples of how the ‘micro-contexts’
(or settings) of drug injecting influence individuals’ proximity to
risk. Additionally, some studies have considered the impact of dif-
ferent ‘macro-contexts’ on risk behaviour. Grund and colleagues,
for example, compared ethnographic data on the contexts of drug
injecting in Rotterdam and the Bronx, New York (Grund et al.,
1992a). They suggest that the differential rates of injecting risk
behaviours and the extent to which informal support networks
exist among IDUs differ on account of the wider social and politi-
cal contexts of the two cities.
It is, therefore, important to note that the social settings in which
drugs are injected, and the influence such settings have on IDUs’
capacity for risk reduction, are themselves shaped by wider structural
and political factors, such as drug-enforcement activities, geography
and housing (Arlacchi and Lewis, 1990a; Gamella, 1994; 1997a).
As noted earlier, the studies by Gamella in Valdemina, Madrid,
provide an example. These illustrate how proximity to risk associ-
ated with drug injecting was linked to two neighbourhood factors
which occurred prior to the emergence of HIV. The first was that
pharmaceutical drugs were available in local pharmacies long
before young people developed an interest in using them. The sec-
ond was that, over time, for primarily economic and social 
reasons, these drugs began to be injected. This, in turn, led to the
increased injection of heroin, by which time the ‘social diffusion’
of drug injecting practices had coincided with the presence of HIV.
This study views key aspects of the social context, including eco-
nomic, geographical and other structural factors, as determinants
of HIV risk associated with patterns of drug injecting.
POWER AND NEGOTIATION
While qualitative research points to most sharing between IDUs as
a positive response to the rights and obligations of social relation-
ships, this should not blind us to the fact that some of the relation-
ships which pattern needle and also drug sharing ‘embrace fear
and domination rather than intimacy and trust’ (Bloor, 1995,
p. 66). This leads us to consider power as an additional contextual
variable influencing risk behaviour. Patterns of drug and equip-
ment sharing, as well as opportunities for risk reduction, are often
expressive of the distribution of power in relationships (Bloor,
1995; Rhodes and Quirk, 1996; 1998), and along gender lines in
particular (Barnard, 1993a; Klee, 1993; Taylor, 1993).
A number of studies suggest that female IDUs are more likely
only to share needles and syringes with their male sexual partners
— often after their male partners have used them first (Freeman et
al., 1994) — while men are more likely to share with other male
friends (Rua-Figueroa et al., 1992; Barnard, 1993a).
Qualitative studies have shown that wider perceptions of gender
roles, and an unequal distribution of power between men and
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women in relationships, may extend to patterns of risk and
responsibility regarding drug use (Taylor, 1993), including gaining
access to clean injecting equipment (Barnard, 1993a). One study
in Dundee, Scotland, for example, found a connection between
domestic violence and HIV risk behaviour (Aalto and MacRae,
1997). This study found that challenges or questions by female
IDUs about the risk behaviour of their male partners may some-
times be perceived as a threat to the status quo of relationships,
which could, and often did, result in violent reprisal. The distri-
bution of power in relationships, and thus also of risk negotiation,
may therefore be ‘gendered’ (Coppel, 1989; Barnard, 1993a;
1993b; Zurhold, 1993).
To date, there has been little European qualitative research focus-
ing on the role of conflict and dominance (both within relation-
ships and within IDU social hierarchies) in the negotiation of
drug use or sexual risk behaviours among IDUs. However, studies
describing the more ‘predatory’ aspects of IDU sub-cultures indi-
cate that conflicts over drugs can be commonplace (Grund et al.,
1996).
Some UK-based qualitative research has shown arguments and
conflicts over the shared distribution of drugs to feature in cou-
ples’ relationships where both partners are regular drug users
(Rhodes and Quirk, 1998). Such conflicts are probably most
likely where both partners are drug-dependent and where
resources are scarce. At some level, these conflicts and their
potential for their violent resolution may influence HIV risk
behaviours.
CULTURES OF RISK BEHAVIOUR
Qualitative research has highlighted that the difficulties IDUs
have in achieving safer injecting can no longer be considered as
merely an outcome of the lack of availability of clean injecting
equipment or a lack of knowledge of the risks entailed. They may
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relate more fundamentally to the dynamics of drug dependency
and the complex set of social ties and obligations characterising
IDUs’ social and sexual relationships.
Crucially, as Grund and colleagues (1996) have pointed out,
drug-related sharing (with its associated risks of blood contamina-
tion) may function as an integral part of the IDU ‘subcultures’.
Characteristic of many interactions associated with the buying,
dividing and using of drugs, the sharing of injecting equipment
may be a particularly potent expression of the ‘almost universal
subcultural code of “share what you have”’ (Grund, 1993).
The ‘risk culture’ of IDU subcultures comprises a combination of
social and structural factors. Although what Grund describes as
the ‘almost universal sub-cultural code of sharing’ has been found
to exist for economic reasons (as with the availability and afford-
ability of clean syringes), it is also associated with the criminal
and socially stigmatised nature of drug dependency (Noller and
Reinicke, 1987; van Gelder and Sijtsma, 1987; Noller, 1989;
Kemmesies, 1995). In the face of constant adversity and external
pressure, IDUs are mutually dependent upon each other, both
positively and negatively, for information and help in locating
and financing drug use as well as the management of drug use.
This ‘dependency’ has been noted elsewhere, in ethnographic
studies by Bourgois (1997) and Power and colleagues (1996).
While useful in some respects (to stave off withdrawal, to
share costs), drug sharing has been observed to perform a
wider set of more social functions. So, for example, drug
sharing might be used to mediate and resolve conflicts, to
make and sustain alliances, and to compensate for previous
violations between IDUs (Grund et al., 1991; 1996;
McKeganey and Barnard, 1992b; Rhodes and Quirk, 1998).
The social character of drug and injecting equipment sharing
and its ascribed social value within IDU networks and rela-
tionships greatly adds to the difficulties of reducing the risks
associated with these behaviours.
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OVERDOSE
At this point, it may be concluded that risk perceptions associated
with sharing practices, as with any risk behaviour, are ‘relative’
and ‘situated’ concerns (Rhodes, 1995; 1997). In understanding
the meaning and context of injecting risk behaviours from the
perspectives of drug injectors themselves, it becomes possible to
understand the relative priority given to particular risk behaviours
and, in turn, the likely acceptability of risk-reduction interven-
tions. Such research highlights HIV and hepatitis risks as relative
concerns within a wider context of ‘risks’ and ‘dangers’ associated
with drug injecting (Delor, 1997). This study, as most, has con-
centrated on injecting risk associated with needle and syringe
sharing, but other relative risk concerns associated with injecting
may include the following:
• general needle hygiene;
• vein damage;
• infections to the injecting site;
• the risks associated with making particular injections 
(for example, groin injections);
• the risk of purchasing fake drugs;
• the risk of arrest; and
• the risk of overdose.
In particular, there is evidence — particularly among Australian
researchers — of increased interest in the risk management and
experience of overdose. Qualitative research on overdose might
be identified as a key priority for future European research on risk
associated with drug injecting. Overdose is a major contributor to
the increased rates of mortality among IDUs in most European
countries. Qualitative studies present opportunities for under-
standing the situational factors associated with overdose as well
as for developing appropriate overdose prevention and risk man-
agement interventions. Concerted actions on HIV prevention
among IDUs have been associated with encouraging behaviour
changes, as well as stabilisation of HIV prevalence at low levels
among IDU populations (Stimson et al., 1996). If low-cost 
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interventions can be shown to reduce risk associated with over-
dose and overdose-related fatality, it is likely that significant pub-
lic health gains will be made.
UK qualitative research points to opioid overdose being viewed
by IDUs as one of the ‘main risks’ associated with injecting but
also as a ‘legitimate’ or ‘acceptable’ risk associated with everyday
drug injecting (Rhodes, 1995). Recent Australian studies have
illustrated that the design of community-level overdose preven-
tion and risk management interventions are best informed by
qualitative assessments of IDUs’ perceptions of risk, their attitudes
and responses to overdose, as well as their current overdose risk
management and coping strategies (Centre for Information and
Education on Drugs and Alcohol, 1997; Davidson and Moore,
1999; Loxley and Davidson, 1999). These studies have noted the
scope for:
• targeted risk-awareness interventions (focusing on the risks of
polydrug use in particular);
• skills-oriented interventions on risk management (focusing on
first aid, including resuscitation); and
• peer-education interventions (both in the community and at
hospital emergency departments).
Australian and UK studies (primarily quantitative) have also
explored the feasibility of training IDUs in first aid and in distrib-
uting naloxone as a means of preventing overdose fatalities
(Darke and Hall, 1997; Strang et al., 1999).
There is currently a dearth of European research on overdose risk
management associated with drug injecting. The development of
risk-reduction interventions in Europe would greatly benefit from
a series of qualitative research projects focusing specifically on
opioid overdose and its risk management.
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UNPROTECTED SEX AND CONDOM USE
The predominant focus of risk behaviour research among IDUs
has been needle and syringe sharing. Fewer studies have focused
specifically on sexual risk behaviour among IDUs, or on the inter-
actions between drug injecting and perceptions of sexual risk.
This is despite evidence pointing to the importance of sexual HIV
transmission among IDUs (Battjes et al., 1994; Friedman et al.,
1994). By the mid-1980s, however, a number of European quali-
tative studies sought to understand the HIV-related sexual risk
behaviour of injecting drug users, sex workers and their sexual
partners. Key studies arguably included:
• McKeganey and Barnard’s ‘AIDS, drugs and sexual risk’ (1992a)
in Glasgow;
• the studies in London on ‘Drug taking and sexual lifestyles’ by
Rhodes et al. (1995); and
• the separate studies in Paris by Ingold and Coppel (Coppel et
al., 1990; 1993; Ingold, 1996; Ingold and Toussirt, 1997).
These projects ran in tandem with other qualitative studies investi-
gating the sexual behaviour of non-injecting populations (for exam-
ple, Holland et al., 1991), as well as sexual risk management among
people living with HIV infection, including IDUs (McKeganey,
1990; Carricaburu and Pierret, 1992; 1995; Tellier and Sobel, 1994;
Delor, 1997; Cusick and Rhodes, 1999; Rhodes and Cusick, 2000).
Most surveys have shown scant indications of sexual behaviour
change among drug injectors (van den Hoek et al., 1992; Fried-
man et al., 1994; Ingold and Toussirt, 1997). There is a general
consensus in quantitative studies that the majority of IDUs ‘never’
use condoms with their primary sexual partners, and that a sub-
stantial minority (usually about a third) ‘never’ use condoms with
their casual partners (Rhodes et al., 1993; Battjes et al., 1994;
Friedman et al., 1994; Davoli et al., 1995; Malliori et al., 1998).
This is particularly the case in long-term relationships, or in rela-
tionships with ‘primary’ or ‘regular’ partners. Not only have qual-
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itative studies supported the contention that sexual behaviour
changes among IDUs have been less likely than changes in
injecting risk behaviour, but they have lent additional insights as
to why this is the case. Some of these findings are summarised
below.
SEXUAL RISK PERCEPTION
One of the most important observations made by qualitative
researchers is that risk is perceived as a relative concern (Coppel
et al., 1990; McKeganey and Barnard, 1992a; Bloor, 1995; Carri-
caburu and Pierret, 1995; Rhodes, 1995; Delor, 1997). Studies
highlight that IDUs perceive sexual risk in the context of a range
of other risks and dangers, such as those associated with ‘addic-
tion’, overdose or needle sharing, which may be perceived to be
more immediate and more important (Rhodes and Quirk, 1996;
1998).
As illustrated in Figure 11, qualitative studies have highlighted
that differential perceptions of risk exist between those associated
with needle and syringe sharing and those associated with sexual
risk behaviour, where risks associated with needle sharing are
often given higher risk priority.
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‘I haven’t used condoms. That’s where I think people slip up.’
‘I’m in a situation where I am a drug user and don’t wanna share needles
and forget about the sexual side, and think that I’ll be OK.’
‘I go out and get my syringes and they have a condom with them. But I
can honestly say that if it came to it and I was in bed, I could quite easily
go along with it, without a condom.’
‘We sleep together (without condoms) but I’d never share.’
‘I know he’s been around sexually but it was just the drugs I thought
about.’
FIGURE 11: SEXUAL RISK PERCEPTION AMONG IDUS
Source: Rhodes and Quirk, 1996, p. 166–167.
As a consequence, studies have found that IDUs’ assessments of
sexual risk are often more likely to be based on perceptions of
risk about a partner’s drug use rather than their sexual history.
The sexual transmission of HIV may often be overlooked by
IDUs (Delor, 1997). While drug injectors may refrain from shar-
ing needles and syringes, they may continue to have unprotected
sex, particularly with long-term partners (with whom they may
refuse to share needles) (Rhodes and Quirk, 1996; Ingold and
Toussirt, 1997).
In private sexual encounters, a key exception to this appears to
be when one of the partners is known to be HIV positive
(Friedman et al., 1994), although unprotected sex between HIV-
positive IDUs and their positive or negative partners also occurs
(Hickey et al., 1994). One qualitative study exploring sexual
negotiation between HIV-positive drug users and their sexual
partners, for example, found that over 60 % reported unpro-
tected sex since their positive diagnosis (Rhodes and Cusick,
2000).
The common occurrence of unprotected sex in IDUs’ relationships
has led qualitative researchers to investigate the contextual factors
associated with sexual risk perception and the negotiation of sex-
ual safety. 
These studies have aimed to describe the factors underpinning
IDUs’ differential perceptions of risk between needle and syringe
sharing and unprotected sex. As noted below, they point to the im-
portance of understanding the social meanings people attach to
condom use and unprotected sex, the contextual factors influen-
cing perceptions of ‘sexual risk acceptability’ in relationships, and
the influence of power in sexual and relationship negotiation.
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THE SOCIAL MEANINGS OF CONDOM USE
Condom use, like any human action, is the product of what can
be termed a ‘situated rationality’ of risk perception (Bloor, 1995).
As a symbolic act, the situated meanings communicated by
unprotected sex — be these ‘trust’, ‘commitment’ or ‘love’ — may
be temporally perceived to outweigh the potential HIV risks or
harms. As observed by Sibthorpe in a study of condom use
among IDUs, the meanings attached to condom use are ‘socially
constructed’ (Sibthorpe, 1992).
This study showed how the social-historical constructions of
condom use as being associated with sexually transmitted
disease, protection and ‘otherness’ influence IDUs’ perceptions
of the meanings communicated by having protected sex.
Whereas protected sex is associated with emotional distance,
unprotected sex may be associated with the realisation of inti-
macy in relationships (Day, 1990; Holland et al., 1991; Wight,
1993). The acts of using, and of not using, a condom come to
have symbolic value.
Studies show that most IDUs perceive unprotected sex to be a
normal feature of heterosexual relationships. Perceived norms
among IDUs may encourage safer drug use practices, yet
perceptions of wider sexual norms may encourage unsafe sexual
practices among IDUs (McKeganey and Barnard, 1992a;
Sibthorpe, 1992; Rhodes and Quirk, 1996). In this situation, the
normative social meanings attached to condom use in relation-
ships — where unprotected sex may be viewed as communi-
cating ‘trust’, ‘commitment’ or ‘love’, and protected sex is
viewed as communicating the presence of ‘risk’, a ‘temporary’
relationship, and need for ‘protection’ — may have to change
before IDUs’ individual perceptions of sexual risk become
malleable (Coppel et al., 1990; 1993; McKeganey and Barnard,
1992a; Ingold, 1996). Qualitative studies thus point to the
importance of changing the wider sexual and social norms
which influence patterns of condom use, which in turn influ-
ence IDUs’ personal beliefs and behaviours.
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One brief example helps to illustrate this point. This concerns the
ethnographically derived notion of ‘unsafe protected sex’ (Quirk
et al., 1998). Defined as the practice where condoms are used
unsafely, two forms of ‘unsafe protected sex’ (UPS) identified by
ethnographic research in London included:
• using condoms for ejaculation only; and
• using condoms after a limited amount of unprotected penetra-
tion has taken place.
As with the development of more sensitive measures of needle
and syringe sharing based on ethnographic research (Grund et al.,
1990; Koester and Hoffer, 1994; Koester, 1996), the identification
of UPS to some extent questions the reliability and sensitivity of
survey measures of sexual risk based simply on the frequency of
condom use.
Additionally, it gives insight into the social meanings people attach
to condom use. In the context of perceived social norms which
legitimate unprotected sex as a normal feature of most drug users’
heterosexual relationships, some condom use may be perceived or
rationalised as better than no condom use (Quirk et al., 1998).
UPS was found to suggest a progression from condom use to non-
condom use in a relationship, and may thus have symbolic value
in making ‘permissible’ a certain amount of unprotected sex,
which, in turn, may make a transition towards non-condom use
easier to justify and negotiate (Quirk et al., 1998).
THE SOCIAL CONTEXT OF RELATIONSHIPS
Just as particular contexts of drug use may ‘structure’ individuals’
injecting risk behaviour (Ouellet et al., 1991; Turnbull et al.,
1996; Wiebel, 1996), particular social relationships fashion sex-
ual behaviour norms. Studies have repeatedly shown that IDUs
are more likely to use condoms in the context of their casual than
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primary relationships, and that these differences are associated
with the differential social meanings attached to protected and
unprotected sex in heterosexual primary and casual encounters
(Coppel et al., 1990; Day, 1990; McKeganey and Barnard, 1992a;
Sibthorpe, 1992).
Such associations indicate how adherence to safer sex is, to some
extent, dependent on the social context of sexual encounters. In
many sexual relationships, particularly if they are viewed as ‘pri-
mary’, the perceived benefits of unprotected sex may be seen to
outweigh the potential costs or risks (Ingold and Toussirt, 1997),
and making a transition from condom use to non-condom use in
long-term or ‘serious’ relationships has been found to be viewed
by most heterosexuals as a ‘normal’ thing to do (Rhodes and
Quirk, 1996). Qualitative studies suggest that breaking a prece-
dent of condom use may provide a symbolic display that rela-
tionships have indeed become ‘primary’ or ‘serious’. Whether or
not condoms are used may thus help define the nature of a rela-
tionship.
The social context of relationships clearly has an important bear-
ing on the social meanings people attach to condom use, as well
as the ways in which condoms are used. This appears to be the
case in both IDUs’ and non-IDUs’ relationships. A common find-
ing across studies among IDUs, gay men and heterosexuals with
no experience of drug use is that transition from condom use to
non-condom use coincides with the development of a relation-
ship as emotional, committed or serious, whereby the social
meanings of condom use both define and communicate people’s
relationships as such. 
The implication of this is that there remains a need for interven-
tions to target changes in the normative social meanings of the
condom as a symbol of non-commitment in relationships, as well
as a need to target relationships, and not only individuals, as units
of sexual behaviour change.
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POWER AND NEGOTIATION
Studies of IDUs’ sexual relationships have identified gender as a
key factor influencing the potential direction of the spread of HIV
(Coppel, 1989; Barnard, 1993a; 1993b). Many female IDUs are
in relationships with men who are also IDUs. However, many
men involved in drug injecting are in relationships with women
who do not themselves inject or use drugs (Barnard, 1993a; Klee,
1993; 1996). Many of these women will not necessarily know
about their partner’s involvement in injecting drug use, at least at
the outset, and often well into the relationship (Kane, 1991). The
stigma attached to injecting drug use is such that disclosure is
often avoided by many for as long as possible. Women are at sub-
stantial risk of HIV infection if their partner has shared needles
and if condoms are not used.
Research also suggests that power in sexual relationships is
unevenly distributed by gender (Holland et al., 1991). This
becomes particularly important in the context of the negotiation
of condom use, and a number of studies emphasise that women
may often find it difficult to initiate or negotiate condom use in
relationships (Coppel, 1989; Coppel et al., 1990; McKeganey and
Barnard, 1992a; Barnard, 1993a; 1993b).
Some studies have found that women’s attempts to initiate con-
dom use can result in emotional coercion towards unprotected
sex and the threat of violence from their male partners, and in
some cases physical violence is reported to have occurred as a
consequence (Aalto and MacRae, 1997). 
These findings highlight that interpersonal communication
between women and men in sexual relationships is itself influ-
enced by wider perceptions of gender role and gender inequality.
They also highlight that the structure of relationships themselves
is an appropriate factor in mediating risk reduction.
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SEX WORK AND CONDOM USE
Public health anxieties as to the possible role played by prostitu-
tion in spreading HIV infection encouraged a number of studies
which investigated risk behaviour associated with sex work. Most
were epidemiological in orientation, concentrating on mapping
the distribution of HIV transmission and risk behaviours among
sex workers and their clients.
Two UK studies specifically concerned with the prevalence of
HIV infection among prostitutes in London and Glasgow carried
out anonymous saliva sampling (McKeganey and Barnard, 1992b;
Ward et al., 1993). Both studies were also concerned with the
sociology of sexual behaviour in the context of prostitution, as
was one other ethnography of street and non-street prostitution
conducted in Glasgow by Cusick (1998).
An additional study was carried out in Manchester by Faugier and
colleagues (1992), which, while largely quantitative, also consid-
ered the social context of HIV transmission among IDUs involved
in sex work, as have a number of qualitative studies in France
(Coppell et al., 1990; 1993; Ingold, 1996). Two key ethnogra-
phies of the connections between drug use and prostitution also
include the life history and lifestyle studies of the heroine-
prostitutie undertaken, 10 years apart, by van de Berg and Blom
(1987; 1997).
A substantial component of the study carried out in Glasgow by
McKeganey and Barnard (1996) among street prostitutes was
qualitative in orientation. Like the ethnographic work of Cusick in
the same city (1998), this involved many hours of observation in
sex work settings as well as in-depth interviews with prostitute
women and their clients (McKeganey, 1994; McKeganey and
Barnard, 1996). Both studies investigated the determinants of
condom use in sex work settings as well as with non-paying sex-
ual partners. It is a common finding of such studies that condoms
are viewed as a symbolic marker distinguishing commercial sex-
ual encounters from private ones (Coppel et al., 1990; Day, 1990;
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Faugier et al., 1992; McKeganey and Barnard, 1996; Cusick,
1998). Whereas condom use may be considered a routine feature
of sex in occupational settings, it may be considered inappropri-
ate in private, primary relationships.
Although the majority of female sex workers report consistent
condom use with clients, qualitative studies have sought to pro-
vide insights into the circumstances in which condoms are not
used (Cusick, 1998). Such studies point to client non-compliance,
as well as threatened or actual violence as key factors (Barnard,
1993b; McKeganey and Barnard, 1996). Evidence from the Man-
chester study also suggested that condom use was less consistent
where the women involved were also IDUs (Faugier et al., 1992).
Taken together, the studies by McKeganey and Barnard (1996),
van de Berg and Blom (1997), Faugier and colleagues (1992) and
Cusick (1998) note an interplay between drug use and sex work
in different occupational contexts, and the potential for sexual
negotiation to be compromised by drug-related withdrawal or
intoxication.
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INTERVENTION DEVELOPMENT
This publication has explored the role of qualitative research in
understanding the lived experiences, social meanings and
social contexts of injecting drug use and related risk behaviour.
Here, we conclude by summarising the practical relevance of
qualitative research findings for intervention and policy devel-
opments.
Meaning, context and response
Understanding the distribution and determinants of behavioural
disease requires multi-method research approaches capable of
capturing the interplay of individual and environmental factors
which influence risk. The individual and public health harms
most commonly associated with injecting drug use are, to a large
extent, preventable through behavioural change. Yet many of the
factors conducive to harm distribution or reduction are also
beyond immediate individual agency or control. These include
the micro- and macro- factors which make up local ‘risk environ-
ments’, of which national and local policy are important parts
(Rhodes et al., 1999a).
It is therefore important to gain a close appreciation, especially
from the perspectives of IDUs themselves, of the individual and
contextual dynamics of risk behaviour associated with drug
injecting. As has been seen, a key role for qualitative research is
to understand the social meanings and social contexts of
injecting drug use and associated risk behaviour in order that
appropriate risk-reduction interventions are developed. If the
harms associated with drug injecting are to be prevented, the
first step towards risk-reduction interventions is to understand
how IDUs perceive risk behaviour and risk reduction in the
context of their own experiences and lifestyles. It is better for
intervention developments to be grounded in experience than in
theory alone.
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Ethnographic insights
The insights generated by qualitative studies of risk behaviour
have immediate relevance for risk reduction. First, the identifica-
tion and description of specific risk behaviours informs public
health risk assessment, planning and targeting. As the contribu-
tion of ethnography to defining risk practices such as ‘indirect’
sharing and ‘unsafe protected sex’ has illustrated (Koester, 1996;
Quirk et al., 1998), ethnographic description is an important first
step in determining the extent and nature of behavioural change
necessary for risk reduction to take place. Second, an under-
standing of the social meanings and social contexts of drug use
helps inform the feasibility and relevance of planned or imple-
mented interventions.
The efficacy of intervention developments is dependent on the
extent to which they are perceived as appropriate by target pop-
ulations and the extent to which social and contextual factors
impede or facilitate their delivery. An understanding of the ‘risk
environment’ in which drug injecting and intervention develop-
ments take place is paramount in developing effective public
health responses. As Wiebel notes of the role of ethnography in
HIV prevention:
‘Ethnography’s role is twofold. First, to document the
norms, values and situational factors relating to HIV risk
practices among targeted social networks. Second, to
document changes in HIV risk practices over time and
identify obstacles and facilitators to such change.’ (Wiebel,
1996, p. 190).
Qualitative research thus enables interventions to be developed
in cognisance of local needs, norms and practices. Undertaking
action-oriented qualitative research supports intervention devel-
opments by identifying who best to target, with what type of mes-
sages or materials, and how best to deliver them. The work con-
ducted by Power and colleagues (1996) in London provides a
brief example. In their study of the coping strategies of IDUs not
in contact with helping services, they explored the interplay
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between drug-user networks and informal risk-reduction strate-
gies. This led to a detailed description of the ways in which drug
users manage risk through peer support networks. In response,
the research made a strong case for the design of peer education
and social network interventions as a means of encouraging
social and community change. The study arrived at five key con-
clusions for the development of successful risk reduction among
IDUs (Power et al., 1996, pp. 151–157):
• interventions should build on the structures of drug-user social
networks;
• interventions should encourage positive aspects of informal risk
management;
• interventions should discourage behaviours that are prejudicial
to risk management;
• drug arenas present opportunities for community-based inter-
ventions; and
• roles within the drug market can assist community interven-
tions.
Interventions based on an ethnographic appreciation of drug use
and risk behaviours are therefore ‘grounded’ in ways which
ensure their practical relevance and acceptability to IDUs them-
selves (Koester, 1996; Wiebel, 1996). It is, therefore, important to
conduct ethnographic and ‘situational’ assessments before the
development of new interventions.
This point is reinforced by a brief reference to an intervention
designed to prevent initiation into injecting drug use reported by
Hunt and colleagues (1998). This intervention was developed on
the basis of ethnographic interviews as well as on previous work
by others which had identified a resistance among IDUs to initiate
non-IDUs into injection (Shelley et al., 1993; Crofts et al., 1996).
Based on this knowledge, the intervention capitalised on informal
risk-management strategies already existing within IDU networks.
The intervention met with acceptance among IDUs. It resulted in a
reduction in the number of times IDUs injected in front of non-
IDUs, a fall in the number of requests to be initiated, as well as a
fall in the number of people initiated (Hunt et al., 1998).
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Process evaluation
IDUs’ access to, and utilisation of, services has been a central
focus of a number of qualitative studies evaluating IDUs’ views
and experiences of services, as well as the management and day-
to-day running of services themselves. The use of qualitative tech-
niques such as observation, in-depth interviews and focus groups
has been a key feature of many evaluations of HIV and drug-
service delivery. These have included studies of drug rehabilita-
tion and drug substitution treatment (Korf and Hoogenhout, 1990;
Rosado and Escursell, 1994; Sickinger, 1994; Quemada Nieto,
1995; Schroers, 1995; Lilly et al., forthcoming), syringe exchange
and distribution (Grund et al., 1992b; Kaplan et al., 1992), risk
reduction in sex work contexts (Coppel et al., 1993; Rotilly,
1997), and evaluation of outreach and community-based inter-
ventions (Boullenger et al., 1991; Rhodes et al., 1991; Grund et
al., 1992a; Kaplan et al., 1992; Rhodes and Holland, 1992; De
Ruyver et al., 1995; Schroers, 1995).
Taken together, these studies emphasise the role of qualitative
methods in understanding the contextual factors influencing inter-
vention feasibility, organisation and performance, client expecta-
tions and views, and client–worker interactions. Qualitative
methods, and a focus on client and worker perceptions of inter-
vention delivery and efficacy, should be considered essential fea-
tures of evaluation design.
Action research and rapid assessment
There are clear public health benefits to be realised by explicitly
linking research to intervention development and evaluation. This
has led to an emphasis on developing qualitative models of
action research and intervention models incorporating ethno-
graphic assessment (Coppel et al., 1990; Sterk, 1993; Wiebel,
1996). One incisive example has been the development of mod-
els of community outreach which integrate ethnographic descrip-
tion as a key means to intervention design. The Indigenous Leader
Outreach Intervention Model developed in Chicago, for example,
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uses ethnographic research to identify communication channels
within particular networks of IDUs as a means of targeting peer
leaders as prevention advocates (Wiebel, 1996). Successful out-
reach interventions often combine the role of ethnographic field-
worker with that of health educator (Sterk, 1993).
There has been increased interest in developing multi-method
approaches to ‘rapid assessment and response’ (Rhodes et al.,
1999c; Stimson et al., 1999). Rapid assessment aims to fill the
gap which commonly exists between conventional social science
research and intervention. Whereas the link between conven-
tional research and response development is often ill-defined,
rapid assessment is undertaken specifically in order that locally
appropriate responses are developed as rapidly as possible. It is
argued that rapid-assessment approaches may be particularly
effective in helping to limit the diffusion of epidemic outbreaks,
such as HIV transmission associated with injecting (Stimson et al.,
1999). Such methods, which borrow from the methodological
principles underpinning qualitative methods more generally, are
becoming increasingly popular in the drugs field.
RESEARCH DEVELOPMENT
The time of AIDS has brought about renewed interest in the use
of qualitative methods, demonstrating that such methods are 
ideally suited to:
• conducting research among hidden populations ‘at risk’;
• identifying and interpreting drug use and risk behaviours; and
• developing social interventions in response.
Research in the time of AIDS has highlighted the role of qualita-
tive research in both understanding the social context of drug use
and risk behaviours as well as responding with pragmatic recom-
mendations for intervention and policy developments (EMCDDA,
2000a).
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Here, we conclude by summarising briefly the implications of the
review drawn up by the EMCDDA working group on injecting
drug use and risk behaviour for future European qualitative
research on drug use.
European qualitative research
Qualitative research is a recent development in many European
countries, and qualitative research on drug use, specifically,
remains embryonic in most. This is the case in central and east
European countries as well as some countries in western Europe.
This reflects historical developments in social-science method and
disciplinary focus more generally, as well as the relative position-
ing of social science — and sociology and anthropology, in partic-
ular — to psychology, psychiatry and medicine in drugs research.
This leads us to conclude that there is a need for multi-site 
collaborative projects between European countries, facilitating
qualitative analyses of health risks in the context of drug injecting
and opportunities for the transference of methodological expert-
ise. The question of the extent to which qualitative forms of data
collection and analyses can be comparable across countries
would itself provide an appropriate means for assessing the needs
and opportunities for transferring qualitative research expertise.
In addition to the encouragement of multi-site research projects,
we also conclude that there is a continued need to make accessi-
ble the data and findings derived from European qualitative
research on drug use. The EMCDDA web site on qualitative
research at http://www.qed.org.uk is an attempt to do this.
This latest volume in the Insights series does not provide an
exhaustive review but constitutes a preliminary attempt to clarify
the role of qualitative research in researching risk associated with
injecting drug use.
Much European qualitative research continues to be reported as
‘grey literature’. This is, in part, a reflection of its perceived status
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in many countries as a ‘secondary’ source of data in projects ori-
ented to quantitative data collection, the scarcity of peer-
reviewed publication outlets available, the relative lack of institu-
tional infrastructures and resources promoting expertise in quali-
tative methodology, and, in part, a reflection of language differ-
ences (quantitative findings are easier to ‘translate’ across lan-
guages than qualitative findings, which emphasise ‘text’ and
‘nuance’ in interpretation). We are aware, for example, that this
volume places greater emphasis on English-language and elec-
tronic publications and, as a consequence, may misrepresent the
range of European qualitative research on drug injecting.
The role of qualitative research
The application of qualitative methods to studies of risk behaviour
and risk reduction associated with drug injecting is at once prag-
matic and methodological. There is a need to combine a variety
of methodological approaches in the study and development of
responses to public health problems associated with drug use.
We conclude that research approaches which combine the use of
multiple methods with multiple sources of data are likely to
increase the reliability, validity and practical efficacy of judg-
ments made.
Qualitative methods are a necessary feature of multi-method
approaches to understanding and responding to drug use. Not
only does qualitative research complement quantitative research,
it may also question the extent to which a priori research defini-
tions of drug use adequately capture the meanings and lived
experiences of drug use. As we have highlighted above and
throughout, qualitative research has a key role to play in:
• offering methods capable of reaching and researching ‘hidden’
populations of drug users in their natural settings;
• understanding the experience and meaning of drug use as it is
perceived by drug users themselves;
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• understanding how different social situations and contexts
influence patterns of drug use;
• understanding the interplay of social and environmental factors
which influence the experience and context of drug use;
• identifying and describing specific drug-use practices and
associated risk behaviours;
• informing the extent and nature of behaviour changes neces-
sary for risk reduction to take place;
• informing the development of appropriate, feasible and effec-
tive risk-reduction interventions;
• understanding the interplay of social and environmental factors
which influence intervention efficacy; and
• evaluating the process of intervention delivery and organisation
and its perceived effectiveness.
Future qualitative research
Following the tradition established in social-interactional
research, we conclude that social-interactionist studies of drug-
use lifestyles and careers remain important, not only for studies of
injecting drug use, but also for studies of new trends in drug use.
Given that qualitative studies are best suited for understanding
particular social situations, groups or behaviours, it is difficult for
us to generalise as to the precise focus of future European quali-
tative studies.
A number of topics, however, appear to have been under-
investigated — particularly with respect to capturing the interplay
between meaning and context — and to have public health rele-
vance across a number of settings. The research topics we iden-
tify as being of priority for future European qualitative studies on
the health risks associated with drug injecting are summarised in
Figure 12.
Lastly, we emphasise the utility of intervention-based, action-
oriented and rapid-assessment projects. Noting that qualitative
methods are under-utilised in the development of risk-reduction
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interventions — such as syringe exchange, outreach, peer inter-
vention and substitution treatment — we see great potential for
the application of qualitative methods in the development, evalu-
ation and description of interventions targeting IDUs.
Such studies should also be seen as creating opportunities for
understanding the social meanings, experience and context of
risk behaviour, and risk reduction more generally, including
among IDUs who remain ‘hidden’ from such interventions.
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• Factors influencing the individual risk management of overdose 
• Risk perception, help-seeking and treatment experience associated
with hepatitis C
• Risk perception, help-seeking and treatment experience among HIV-
positive IDUs
• The influence of gender and power in risk behaviour and risk reduction
• Qualitative evaluation of IDUs’ experiences of syringe exchange,
outreach and drug treatment
• Development of rapid-assessment models to assist intervention
development
• Development of cross-national studies and capacity building
FIGURE 12: TOPICS FOR FUTURE RESEARCH
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